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Abstract 
 Optically active compounds play crucial and important roles in the 
pharmaceuticals, flavors, and fragrance industries resulting in significant 
developments in transition metal-mediated enantioselective reactions. The 
systematic design of chiral ligands is predominant in achieving high 
enantioselectivity. Various publications appeared in this field, along with a Nobel 
Prize in 2001. In this context, since the late 1960s, much research has been conducted 
on chiral bidentate phosphorus ligands in asymmetric reactions. However, enormous 
progress with respect to monodentate chiral phosphorus ligands was also observed 
during the last decade.   
  
 Chapter 1 explores different classes of chiral monodentate phosphorus ligands 
and their use in diverse asymmetric reactions that achieve high enantiomeric ratios. 
 
Chapter 2 describes the synthesis of planar-chiral phosphite ligands with 
paracyclophane scaffold. Their efficiency was tested using two well-established 
asymmetric reactions.  
 
Chapter 3 describes the synthesis of a planar-chiral phosphoramidite ligand with 
a paracyclophanyl scaffold and its use in two well-known asymmetric reactions to 
study its efficiency. 
 
Chapter 4 introduces the indolo[1,2-a]indole skeleton. Various synthetic 
procedures are discussed. 
 
Chapter 5 describes a novel protocol for synthesizing indolo[1,2-a]indole 
derivatives via gold-catalyzed cycloisomerization. Their photophysical properties 
are discussed. 
 
 
 
Chapter 6 concludes by discussing the synthesis of a library of phosphite and 
phosphoramidite ligands. The synthesis and evaluation of indolo[1,2-a]indole 
derivatives is also summarized. 
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List of Abbreviations                                                  
cOH                                 acetic acid 
Ad                                       adamantyl 
Ar                                       aryl 
BINAP                               2,2′-bis(diphenylphosphino)-1,1′-binaphthyl 
BINOL                               1,1′-bi-2-naphthol 
BSA                                    N,O-bis-(trimethylsilyl)acetamide 
BuLi                                    n-butyllithium 
ca.                                        circa 
CAMP                                 cyclic adenosine monophosphate 
CHDA                                  trans-1,2-diaminocyclohexane 
d                                           day(s) 
DCE                                     1,2-dichloroethane 
DCM                                     dichloromethane 
DME                                     1,2-dimethoxyethane 
dig                                         digonal 
DIOP                                     2,3-O-isopropylidene-2,3-dihydroxy-1,4-                  
                                               bis(diphenylphosphino)butane 
DIPAMP                                ethane-1,2-diylbis(2-            
                                               methoxyphenyl)phenylphosphane 
DMAD                                   dimethyl acetylenedicarboxylate 
DTBM                                   3,5-di-tert-butyl-4-methoxyphenyl 
DTBP                                     di-tert-butyl peroxide 
ee                                           enantiomeric excess 
EtOAc                                    ethyl acetate 
ESI                                         electro spray ionization 
equiv.                                      equivalent 
Fig.                                         figure 
HFIP                                       hexafluoroisopropanol 
h                                              hour(s) 
HPLC                                      high performance liquid chromatography 
HRMS                                     high resolution mass spectra 
IR                                            infrared radiations 
 
 
II 
J                                              coupling constant 
L                                              ligand 
m                                             meta 
mCPBA                                   m-chloroperoxybenzoic acid 
Me                                           methyl 
mp                                           melting point 
n                                              normal 
NHC                                        N-heterocyclic carbene 
NIS                                          N-iodosuccinimide 
NMR                                       nuclear magnetic resonance 
N.R.                                         no reaction 
ovn                                          overnight 
p                                              para 
Ph                                            phenyl 
PTLC                                      preparative thin layer chromatography 
sec                                          secondary 
TADDOL                               ’’-tetraaryl-2,2-disubstituted 1,3-  
                                                dioxolane-4,5-dimethanol 
temp.                                       temperature 
THF                                         tetrahydrofuran 
TLC                                         thin layer chromatography 
TMEDA                                   tetramethylethylenediamine 
TMS                                        trimethylsilyl (as a functional group) 
                                                 tetramethylsilane (as a standard material) 
UV                                           ultraviolet 
xyl                                           3,5-xylyl                            
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Chapter 1 
 
General Introduction of  
Chiral Phosphite and Phosphoramidite Ligands   
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• Background 
Importance of developing a new chiral ligand library 
The increasing knowledge of transition metal catalysis has resulted in an extensive 
application of catalysis both in industrial and academic fields. The importance of 
transition metal catalysis is well represented by Nobel Prizes in 2001, 2005 and 2010 
awarded to the researchers working in this field of chemistry. In particular, 
phosphine ligands have significantly contributed towards the evolution of transition 
metal-catalyzed reactions. Various ligand types and structures are reported in the 
literatures: mono-, bi- and polydentate achiral and chiral ligands with different steric 
and electronic properties. This vast ligand library is a result of the rapid evolution in 
the field of organometallic chemistry. Furthermore, catalytic performances of the 
transition metal complexes stimulate the evolutionary growth of the ligand libraries. 
 
Development of the chiral ligand libraries is of utmost importance in terms of 
asymmetric organic transformations. Remarkable achievements have been realized 
in chiral transition metal-catalyzed reactions. The activity of the metal complexes 
can be varied by changing the electronic and/or steric properties of the ligands.  
 
 An important achievement was accomplished by Kagan in 1971 with the 
development of chiral bidentate phosphine DIOP.1 This ligand resulted in the 
corresponding products with up to 72% ee in the enantioselective hydrogenation of 
acylaminocinnamic acid. Knowles synthesized DIPAMP2 that realized an 
enantioselectivity of above 90% and replaced CAMP in the synthesis of L-DOPA, 
which resulted in the optically active drug in up to 95% ee, for which Knowles was 
awarded the Noble prize in chemistry in 2001.3 The next achievement was the 
development of BINAP, an extremely versatile ligand, by Noyori.4 The Ru-BINAP-
catalyzed asymmetric hydrogenation of -keto esters furnished the corresponding -
hydroxy esters with more than 99% ee (Scheme 1).                        
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Scheme 1: Hydrogenation by Ru-BINAP-catalyst 
 
        The Rh-BINAP complex was  used in the asymmetric isomerization of allylic 
amine, which was exploited in the industrial synthesis of (-)-menthol from myrcene.5 
It achieved excellent enantioselectivity of 96% (Scheme 2). The BINAP ligand 
proved to be very versatile and is nowadays used in various asymmetric transition 
metal-catalyzed reactions (Scheme 2). 
 
 
 
 
Scheme 2: Rh-BINAP-catalyzed asymmetric isomerization reaction 
        Various carbon-carbon bond forming reactions, such as cycloadditions, have 
been catalyzed by Rh-BINAP complexes. 
         In 2006, Shibata reported the first example of an asymmetric [2+2+2] 
cycloaddition of 1,6-diynes with electron-deficient 1,1-disubstituted alkenes 
catalyzed by the cationic Rh(I)-BINAP complex (Scheme 3).6 
 
 
 
 
 
 
Scheme 3: Rh-BINAP-catalyzed enantioselective cycloaddition 
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        Chiral multicyclic compounds were also synthesized using the cationic Rh (I)-
BINAP complex in the asymmetric [2+2+2] cycloaddition7 of ,ω-diynes  with 
electron–rich unstrained unsymmetrical 1,2-disubstituted alkenes (Scheme 4). 
 
 
 
 
Scheme 4: Rh-BINAP-catalyzed asymmetric cycloaddition 
 
        Among various carbon-carbon bond forming reactions, the 1,4-conjugate 
addition of organometallic reagents to enones is widely used for the preparation of 
-substituted carbonyl compound, which are important synthons in organic 
transformations. The asymmetric Rh-BINAP-catalyzed 1,4-conjugate addition of 
arylboronic acids to enones has been reported to proceed with high enantioselectivity 
(Scheme 5).8 
 
 
 
 
Scheme 5: Rh-BINAP-catalyzed 1,4-conjugate addition 
 
         Synthesis of enantiomerically pure compounds by using arylboronic acid is 
very demanding because of their stability and facile availability. For example, the 
Rh-catalyzed 1,4-conjugate addition of aryl groups to the electron-deficient 4,4,4-
trifluoro-1-phenyl-2-buten-1-one in the presence of the Rh-BINAP catalyst is well 
known. (Scheme 6).9 
 
 
 
 
 
5 
 
 
 
 
Scheme 6: Rh-BINAP-catalyzed 1,4-conjugate addition 
There has been considerable interest in Heck-type arylation for building carbon 
frameworks of biologically important organic compounds. In the catalytic arylation 
of 2,3-dihydrofuran using aryl triflates as arylating agents, a high enantioselectivity 
was achieved using the Pd-BINAP catalyst (Scheme 7).10 
 
 
 
 
Scheme 7: Pd-catalyzed asymmetric Heck reaction 
 Inspired by the tremendous success achieved using BINAP as a chiral ligand in 
asymmetric reactions, various BINAP derivatives were synthesized to increase their 
catalytic efficiency and to generate a pool of ligands.11 Such derivatization involved 
the replacement of phenyl groups on the phosphorus atom with different substituted 
phenyl groups or aliphatic groups. Variation of the substituents on the binaphthyl 
backbone and the partial reduction of binaphthyl backbone resulted in the H8-BINAP 
family of ligands. These modifications enabled the manipulation of their electronic 
and steric properties. The more electron-rich H8-BINAP contains more steric bulk 
and a larger dihedral angle than BINAP itself. Different atropisomeric C2-symmetric 
diphosphines were also synthesized and studied extensively. Roche reported the 
synthesis of axially chiral diphosphine ligands, BIPHEMP and MeO-BIPHEP. Later, 
SEGPHOS was synthesized via an oxidative coupling, while other modifications led 
to the synthesis of SYNPHOS. The Zhang group developed a series of TunePhos 
ligands, while Burk and coworkers reported the first synthesis of BPE and DuPhos. 
Some of the ligands are shown below in Figure 1. The large family of diphosphine 
ligands not only offers a choice of different catalysts, but also provides a good 
opportunity to explore the catalytic processes. 
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Fig. 1: (R)-BINAP and selected chiral biaryl diphosphines 
H8-BINAP resulted in excellent enantioselectivities of the products in the Ir-
catalyzed reduction of ketones, Rh-catalyzed conjugate additions to ,-unsaturated 
compounds, and other metal-catalyzed cycloaddition reactions.12 
The 1,4-addition of carbon nucleophiles to -disubstituted -unsaturated 
carbonyl compounds is a useful strategy for constructing quaternary carbon 
stereocenters.13 The Rh-H8-BINAP-catalyzed asymmetric 1,4-addition of 
arylboronic acids to 3-substituted maleimides afforded the desired products in high 
regio- and enantioselectivities (Scheme 8). 
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Scheme 8: Rh-catalyzed asymmetric 1,4-addition 
The first catalytic synthesis of tribenzothiepin was carried out by Shibata group, 
with high enantioselectivity.14 Rh-catalyzed cycloaddition was used as a novel 
strategy for the construction of the tribenzoheteropin framework. Intermolecular 
cycloaddition proceeded using the sulfur-containing cyclic system in the presence 
of the cationic Rh-MeO-BIPHEP catalyst (Scheme 9). 
 
 
 
 
 
Scheme 9: Enantioselective synthesis by intermolecular cycloaddition  
Shibata’s group further reported an intramolecular cycloaddition of triynes using 
Rh-DTBM-SEGPHOS, which furnished tribenzothiepins in high yields and 
excellent enantiomeric excesses (Scheme 10).15 
  
 
 
 
 
 
Scheme 10: Enantioselective intramolecular cycloaddition 
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Shibata’s group also reported an enantioselective reaction of substituted 
acetanilides with -substituted -unsaturated esters using the cationic Ir-
DIFLUORPHOS catalyst.16 It was the first example of enantioselective formal C-H 
conjugate addition involving an sp2 C-H bond activation to -substituted -
unsaturated carbonyl compounds (Scheme 11). 
 
 
 
 
 
Scheme 11: Enantioselective formal C-H conjugate addition 
Planar-Chiral Scaffolds in Chiral Ligands 
1) Solvias Ligand 
      Metal complexes having chiral ligands arguably are the most flexible catalysts 
for enantioselective transformation. In the reported literatures, large number of chiral 
ligands result in excellent enantioselectivities of the products in different catalytic 
reactions. However, organic chemists in research laboratories and industries have 
different perspectives. Although a vast library of chiral ligands exists, only a few of 
them, which are termed as “privileged ligands” by Jacobsen, are widely used for the 
synthesis of target molecules. There are many prerequisites for a chiral ligand to be 
employed by organic chemist to solve particular synthetic problems. The ready 
availability of the ligand increases its chances to be used in synthetic applications. 
For the building up of a comprehensive ligand portfolio Josiphos ligand would be a 
good model. Ferrocene-based ligands dominate this portfolio. Next addition to this 
portfolio is Walphos. Two ligand families with modularities similar to Josiphos and 
Walphos are Taniaphos and Mandyphos. The ligand portfolio is depicted in Figure 
2. These ligands fulfil all the criteria of tunability, easy handling, scale-up, and 
manufacturing applications. 
 
 
 
 
 
9 
 
 
 
 
 
 
 
 
Fig. 2: Solvias ligand portfolios 
 A powerful method for the synthesis of enantiomerically pure heteroatom- 
containing compounds are the metal-catalyzed enantioselective additions of 
hydrogen-heteroatom bonds to alkenes. For example, the Pd-catalyzed asymmetric 
hydrophosphorylation of norbornenes17 using Josiphos ligands proceeded 
effectively to result in the corresponding chiral phosphonates in high enantiomeric 
excesses (Scheme 12). 
 
 
 
 
Scheme 12: Pd-catalyzed hydrophosphorylation 
 
1,4-Dienes in natural products and polyunsaturated fatty acids have significant 
biological functions. A highly effective Cu-catalyzed asymmetric allylic alkylation 
of 1,3-dienyl bromides was developed for the enantioselective synthesis of 1,4-
dienes with a methyl-substituted stereogenic carbon center.18 Very good regio- and 
enantioselectivities were achieved using Taniaphos as a chiral ligand in this reaction 
(Scheme 13).  
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Scheme 13: Cu-catalyzed asymmetric allylic alkylation 
Fluorine-containing amino acids are significant components due to their 
biological activities. A catalytic asymmetric cycloaddition reaction with azomethine 
ylides was developed from chiral Walphos ligand and copper(I) perchlorate.19 This 
reaction provides a simple approach to obtain optically active exo 3-
(trifluoromethyl)proline derivatives in high yields and enantiomeric excesses 
(Scheme 14). 
 
 
 
 
 
Scheme 14: Cu-catalyzed asymmetric [3+2] cycloaddition 
2) Cyclophane Ligand 
The demand for optically active compounds is significant and chiral phosphines 
play an important role in asymmetric catalysis for the synthesis of such compounds. 
Phosphines with central or axial chirality are common, while phosphines with planar 
chirality are less studied. The presence of an alternative chiral scaffold i.e, planar 
chirality, opens up new possibilities. Ferrocene derivatives such as JosiPhos contain 
a chiral center in addition to the planar chirality hence, separation of the influence 
of each of these two chiral elements is difficult. In this context, planar-chiral 
cyclophanes attract considerable attention due to their structural and electronic 
properties. The most common cyclophane is [2.2]paracyclophane, in which a 
molecule consisting of two eclipsing aryl rings is  held together at the para position 
by two ethylene moieties. Unusual electronic properties originate due to the close 
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proximity of the benzene rings. The first successfully synthesized chiral phosphine 
ligand possessing the [2.2]paracyclophane scaffold is PhanePhos. It is the most 
commonly studied and versatile cyclophanyl ligands. The first use of PhanePhos was 
made in the hydrogenation of tetrahydropyrazine20 at low temperature, that resulted 
in the corresponding product with 86% ee (Scheme 15). Previously employed 
standard phosphine ligands BINAP and Et-DUPHOS required harsh conditions and 
resulted in moderate ee of the products (56% with BINAP and 50% with Et-
DUPHOS). 
 
 
 
 
 
Scheme 15: Rh-catalyzed hydrogenation 
In the Ru-catalyzed hydrogenation of -keto esters, PhanePhos was also 
employed as a chiral ligand. An excellent enantioselectivity of 96% was achieved in 
the presence of NBu4I at low temperature.21 In contrast, BINAP derivatives gave 
poor results under similar conditions (Scheme 16). 
 
 
 
 
Scheme 16: Ru-catalyzed hydrogenation 
Asymmetric synthesis and the uses of planar-chiral [2.2]paracyclophane-based 
ligands are less explored when compared to the planar-chiral ferrocenyl compounds. 
In the development of new methodologies for the synthesis of optically pure 
derivatives, the chemistry of [2.2]paracyclophane is often used. To investigate their 
applications in catalysis, organic chemists have developed some interest in the 
synthesis of a variety of [2.2]paracyclophanes and successfully expanded the tool-
box (Figure 3). 
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Fig. 3: Different types of [2.2]paracyclophane-based ligands 
The enantioselective addition of organometallic reagents to C=N bonds is one of 
the important reactions for the preparation of chiral amines in homogeneous 
catalysis. Addition of dialkylzinc to imines22 was reported in the presence of the 
[2.2]paracyclophane-based N,O-ligand (Scheme 17).  
   
 
 
 
 
 
Scheme 17: Enantioselective addition of diethylzinc addition to imines 
Planar-chiral P,N-[2.2]paracyclophane ligands were synthesized and studied in 
the asymmetric Pd-catalyzed allylic alkylation.23 P,N-Ligands realized a high 
reactivity and led to the  completion of the reaction within 20 min and gave the chiral 
product in an almost quantitative yield and high ee (Scheme 18). 
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Scheme 18: Pd-catalyzed allylic alkylation 
 [2.2]Paracyclophane ligands as novel cytostatics 
 By the derivatization of [2.2]paracyclophane with tunable polar groups, a 
selective drug can be obtained. [2.2]Paracyclophanyl gold(I) complex has recently 
been explored as a substitute for therapeutically well-known cisplatin (Figure 4).24 
 
 
 
 
 
Fig. 4: Paracyclophane gold(I) complexes as cytostatics  
 Besides [2.2]paracyclophanes, pyridinophane backbones also have the  planar 
chirality. Kanomata has studied the stereocontrolled synthesis of 
parapyridinophanes. An enantioselective cyclopropanation25 was explored using a 
Cu catalyst in the presence of C2-symmetric planar-chiral bridged terpyridines. 
Moderate diastereomeric excess and high enantiomeric excess were achieved 
(Scheme 19). 
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Scheme 19: Cu-catalyzed enantioselective cyclopropanation 
Besides these examples, asymmetric synthesis of planar-chiral paracyclophanes 
was reported by Shibata’s group. Enantioselective ortho-lithiation of 
paracyclophane was carried out to obtain planar-chiral paracyclophanes in good to 
excellent enantioselectivities. Synthetic applications as chiral ligands in asymmetric 
reactions were tested after synthesizing corresponding monophosphino and 
diphosphino paracyclophanes. Silver-catalyzed allylation of arylamine26 with the 
planar-chiral paracyclophanyl phosphine resulted in moderate enantiomeric excess 
of the corresponding product (Scheme 20).  
 
 
 
 
 
 
Scheme 20: Ag-catalyzed enantioselective allylation of imine 
Next, enantioselective double Sonogashira coupling27 of diiodoparacyclophane 
was realized with paracyclophanyl phosphine as chiral ligand, which resulted in the 
product with good enantioselectivity (Scheme 21). 
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Scheme 21: Enantioselective Sonogashira coupling  
• Purpose of The Research in These Chapters 
 As mentioned above, planar-chiral paracyclophane is an attractive privileged 
chiral source that has a major role in the field of asymmetric catalysis. New ligands 
are always required for new reactions. Furthermore, facile methods for the synthesis 
of ligand and the stabilities of the synthesized ligands are foremost essential, and 
hence, generation of a ligand library is very useful.   
In this thesis, the author describes two new approaches for the synthesis of planar-
chiral paracyclophanyl-phosphite/phosphoramidite ligands and examines their 
performance in two benchmark asymmetric reactions. These ligands are versatile 
and allow a fine tuning of substituents. They are stable under ambient conditions and 
thus are easy to handle.  
Chapter 2 describes the synthesis of planar-chiral paracyclophanyl phosphite 
ligands (Scheme 22). They were prepared in two steps from a chiral alcohol and a 
chiral diol. They were tested in two standard asymmetric reactions to check their 
efficiency. 
 
 
 
Scheme 22: Outline review for synthesis of paracyclophanyl phosphites 
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 Chapter 3 describes the synthesis of planar-chiral paracyclophanyl 
phosphoramidite ligands (Scheme 23). A versatile ligand library was built; each 
ligand was obtained in three steps from a chiral amine and a chiral diol. The 
efficiency of the ligands was tested in two well-known asymmetric reactions.  
 
 
 
 
 
 
Scheme 23: Outline review for synthesis of paracyclophanyl phosphoramidites 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
• References 
 
1. Dang, T.-P.; Kagan, H. B. J. Chem. Soc., Chem. Commun. 1971, 481-481. 
 
2. Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D.; Weinkauff, D. J. J. Am. Chem. 
Soc. 1975, 97, 2567-2568. 
 
3. Knowles, W. S. Angew. Chem., Int. Ed. 2002, 41, 1999-2007.  
 
4. Noyori, R.; Ohkuma, T.; Kitamura, M.; Takaya, H.; Sayo, N.; Kumobayashi, H.; 
Akutagawa, S. J. Am. Chem. Soc. 1987, 109, 5856-5858. 
 
5. Tani, K.; Yamagata, T.; Akutagawa, S.; Kumobayashi, H.; Taketomi, T.; Takaya, 
H.; Miyashita, A.; Noyori, R.; Otsuka, S. J. Am. Chem. Soc. 1984, 106, 5208-
5217. 
 
6. Tsuchikama, K.; Kuwata, Y.; Shibata, T. J. Am. Chem. Soc. 2006, 128, 13686-
13687. 
 
7. Aida, Y.; Sugiyama, H.; Uekusa, H.; Shibata, Y.; Tanaka, K. Org. Lett. 2016, 18, 
2672-2675. 
 
8. Takaya, Y.; Ogasawara, M.; Hayashi, T.; Sakai, M.; Miyaura, N. J. Am. Chem. 
Soc. 1998, 120, 5579-5580. 
 
9. Boz, E.; Haslak, Z. P.; Tuzun, N. S.; Konuklar, F. A. S. Organometallics 2014, 
33, 5111-5119. 
 
10. Ozawa, F.; Kubo, A.; Hayashi, T. J. Am. Chem. Soc. 1991, 113, 1417-1419. 
 
11. Gillespie, J. A.; Zuidema, E.; van Leeuwan, P.W. M. N.; Kamer, P. C. J.  
Phosphorus (III) ligands in homogeneous catalysis: Design and Synthesis, 
Wiley 2012. 
 
12. (a) Senda, T.; Ogasawara, M.; Hayashi, T. J. Org. Chem. 2001, 66, 6852-6856. 
(b) Shintani, R.; Duan, W.-L.; Hayashi, T. J. Am. Chem. Soc. 2006, 128, 5628-
5629. 
 
13. Shintani, R.; Duan, W.-L.; Hayashi, T.; J. Am. Chem. Soc. 2006, 128, 5628-5629. 
 
 
18 
 
14. Tahara, Y.; Matsubara, R.; Mitake, A.; Sato, T.; Kanyiva, K. S.; Shibata, T. 
Angew. Chem. Int. Ed. 2016, 55, 4552-4556. 
 
15. Mitake, A.; Fusamae, T.; Kanyiva, K. S.; Shibata, T. Eur. J. Org. Chem. 2017, 
7266-7270. 
 
16. Shibata, T.; Michino, M.; Kurita, H.; Tahara, Y.; Kanyiva, K. S. Chem. Eur. J. 
2017, 23, 88-91. 
 
17. Xu, Q.; Han, L.-B. Org. Lett. 2006, 8, 2099-2101. 
 
18. Huang, Y.; Fananas-Mastral, M.; Minnaard, A. J.; Feringa, B. L. Chem. Commun. 
2013, 49, 3309-3311. 
 
19. Li, Q.; Ding, C.-H.; Li, X.-H.; Weissensteiner, W.; Hou, X.-L. Synthesis, 2012, 
44, 265-271. 
 
20. Pye, P. J.; Rossen, K.; Reamer, R. A.; Tsou, N. N.; Volante, R. P.; Reider, P. J. 
J. Am. Chem. Soc. 1997, 119, 6207-6208. 
 
21. Pye, P. J.; Rossen, K.; Reamer, R. A.; Volante, R. P.; Reider, P. J. Tetrahedron 
Lett. 1998, 39, 4441-4444.   
 
22. Dahmen, S.; Brase, S. J. Am. Chem. Soc, 2002, 124, 5940-5941. 
 
23. Wu, X-W.; Yuan, K.; Sun, W.; Zhang, M. J.; Hou, X.-L. Tetrahedron: 
Asymmetry 2003, 107-112. 
 
24. Bestgen, S.; Seidl, C.; Weisner, T.; Zimmer, A.; Falk, M.; Koberle, B.; Austeri, 
M.; Paradies, J.; Brase, S.; Schepers, U.; Roesky, P. W. Chem. Eur. J. 2017, 23, 
6315-6322. 
 
25. Mugishima, N.; Kanomata, N.; Akutsu, N.; Kubota, H. Tetrahedron Lett. 2015, 
      56, 1898-1903.  
  
26. Kanda, K.; Hamanaka, R.; Endo, K.; Shibata, T. Tetrahedron 2012, 68, 1407-
1416. 
 
 
 
19 
27. Kanda, K.; Oshima, S.; Shizuno, T.; Hamanaka, R.; Fukai, M.; Shibata, T. 
Heterocycles 2014, 88, 1355-1370. 
 
 
 
 
 
 
 
 
 
 
 
                                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
 
 
 
 
 
Chapter 2 
 
Synthesis of Planar-Chiral Paracyclophanyl Phosphite 
Ligands and Their Application to Asymmetric 
Reactions 
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• Background 
Several natural building blocks have been widely used to develop chiral ligand 
libraries. However, the availability of both (R)-and (S)-BINOLs in optically pure 
forms has directed the synthetic community toward the synthesis of chiral ligands 
and new materials. BINOL derivatives are currently considered as favourable 
backbones of chiral ligands and are used in various catalytic asymmetric carbon-
carbon bond forming reactions including allylic alkylation, conjugate addition, 
and Diels-Alder reaction.1 Moreover, chiral phosphorus ligands with binaphthyl 
scaffold have earned the status of “privileged ligands” due to their wide use in 
asymmetric transformations. A diverse family of chiral phosphorus ligands with 
various chemical properties is prepared by introducing heteroatoms including 
phosphites and phosphoramidites.  
 
Phosphite Ligands 
Phosphites are attractive chiral ligands for developing several catalytic 
asymmetric reactions. Phosphites are generally easy to prepare from readily 
available chiral or achiral alcohols, less sensitive to air, and stable under ambient 
conditions. In the last decade, there has been continuing interest in chiral 
monodentate phosphorus ligands due to their excellent performances in catalytic 
asymmetric reactions including hydrogenation and allylic substitution. Facile 
structural variation of monodentate ligands by straightforward synthesis is highly 
advantageous. In recent years, many ligand libraries of BINOL-based 
monodentate phosphites were developed. During the ligand design, several 
modifications were performed by varying either the alcohol unit or the substituent 
at the binaphthyl moiety. A two-step procedure was generally involved in 
synthesizing monodentate phosphite ligands. Selected examples of asymmetric 
applications of monodentate phosphites are mentioned below. 
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Examples of Chiral Phosphite Ligands: 
 The first highly enantioselective Rh-catalyzed hydrogenation involving a chiral 
monophosphate ligand was reported by Reetz in 2000.2 A BINOL-based 
monophosphite with a chiral alcohol moiety proved to be an excellent ligand 
(Scheme 1). 
 
 
 
 
Scheme 1: Hydrogenation by monodentate phosphite ligand  
 
   Evans et al. reported a highly enantioselective allylic alkylation of acyclic α-
alkoxy aryl ketones using a Rh-catalyst derived from Wilkinson’s complex and a 
chiral monodentate phosphite.3 This was the first enantioselective Rh-catalyzed 
allylic substitution with a prochiral nucleophile. Its ability to transform aryl ketones 
illustrates the potential application of this transformation to target-directed synthesis 
(Scheme 2). 
   
 
 
 
Scheme 2: Rh-catalyzed allylic alkylation  
A new series of monodentate phosphites based on TADDOL was synthesized and 
these operated as efficient chiral ligands in Cu-catalyzed 1,4-conjugate addition 
(Scheme 3).4 
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Scheme 3: Cu-catalyzed 1,4-conjugate addition 
 
      A new series of phosphites based on axially chiral monoesterified H8-BINOL 
and BINOL was synthesized. In the Rh-catalyzed asymmetric hydroformylation of 
styrene,5 these ligands showed excellent chemoselectivity for branched aldehydes, 
but with low enantioselectivity (Scheme 4).  
 
 
 
 
 
 
Scheme 4: Rh-catalyzed asymmetric hydroformylation of styrene 
 
Purpose of This Chapter 
As mentioned above, asymmetric reactions with chiral phosphite ligands 
represent an important tool for obtaining various optically active compounds. Thus, 
the author predicted that enantioselective synthesis of planar-chiral paracyclophanyl 
phosphite would be important in generating a new chiral ligand library. 
In this chapter, the author describes the enantioselective synthesis of planar-chiral 
paracyclophanyl phosphites as shown in Fig.1. Synthesized ligands were used in 
enantioselective Pd-catalyzed allylic alkylation and Rh-catalyzed 1,4-addition to test 
their efficiency. 
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Fig. 1: Outline review for the synthesis of planar-chiral paracyclophanyl phosphites 
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• Results and Discussion  
Chiral phosphites were generally synthesized by reacting achiral or chiral alcohols 
and BINOL or biphenol with phosphorus trichloride (Fig. 2). 
 
 
Fig. 2: Outline review for the synthesis of chiral phosphites 
 
Herein, chiral alcohols (R(*)OH) and BINOL were used, which would 
cooperatively induce high enantioselectivity.6 A combination of planar-chiral 1,n-
dioxa[n]paracyclophane possessing a hydroxyl group and BINOL as a backbone was 
used for the reactions of a new library of phosphites (Scheme 5). A substituent (R’) 
at the para-position is considered to regulate the paracyclophane scaffold sterically 
and/or electronically. 
 
 
 
 
 
 
 
Scheme 5: Synthesis of planar-chiral paracyclophanyl phosphites 
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Synthesis of substituted paracyclophanyl alcohols 
To introduce a hydroxyl group to 1,n-dioxa[n]paracyclophanes, a lithium salt of 
tert-butyl hydroperoxide was selected as an electrophile.7 The reaction of aryllithium 
synthesized from 1,n-dioxa[n]paracyclophanes 1a (n = 8), sec-BuLi, and (+)-
sparteine afforded planar-chiral hydroxyl derivative 2a. Under the same reaction 
conditions, 2b (n = 9) was prepared from 1b. Excellent enantioselectivity was 
obtained in both transformations (Scheme 6).  
  
 
 
 
 
Scheme 6: Synthesis of paracyclophanyl alcohols 
 
 Moreover, the author prepared a para-substituted paracyclophanyl alcohol from 
TMS-substituted paracyclophane 1c. Para-selective lithiation was performed under 
literature conditions.8 A reaction with the lithium salt of tert-butyl hydroperoxide9 
afforded paracyclophanyl alcohol 2c in good yield. A subsequent reaction with NIS 
furnished iodo-substituted paracyclophanyl alcohol 2d as a vital synthetic 
intermediate in good yield. The retention of an enantiomeric excess of 2d was 
confirmed. Para-arylated paracyclophanyl alcohols 2e-2g were prepared by Suzuki 
coupling under literature conditions.10 Retention of an enantiomeric excess was 
verified using compound 2e (96% ee) (Scheme 7). It was slightly decreased. 
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Scheme 7: Synthesis of aryl-substituted paracyclophanyl alcohols 
 
Synthesis of planar-chiral paracyclophanyl phosphites 
 The author subsequently synthesized planar-chiral paracyclophanyl phosphites 
starting from paracyclophanyl alcohol (Table 1). The reaction of 2a with 2,2’-
biphenylene phosphorochloridite 3a in the presence of triethylamine afforded the 
desired planar-chiral phosphite L1 (Entry 1).11 The reaction with 2b similarly 
afforded planar-chiral phosphite L2 (Entry 2). Bulky phosphite L3 containing 
tetramethyl groups on the biphenyl backbone was also prepared from 2b in moderate 
yield (Entry 3). These ligands were stable in air. The reaction with axially chiral 
2,2’-binaphthyl phosphorochloridites 3c furnished (Sa)-L4 and (Ra)-L4 (Entries 4 
and 5). While phosphite (Sa)-L4 was sufficiently stable to be isolated, its 
diastereomer (Ra)-L4 was unstable and easily hydrolyzed even during isolation by 
Florisil® column chromatography. It was subsequently obtained as a mixture of 
phosphite (Ra)-L4 and alcohol 2b (Entries 4 and 5). Para-substituted 
paracyclophanyl phosphite L2(TMS) was also prepared from TMS-substituted 
paracyclophanyl alcohol 2c in good yield (Entry 6). Other para-substituted 
paracyclophanyl phosphites including L2(Ph), L2(MeOPh), and L2(CF3Ph) were 
prepared from 2e-2g according to the same protocol (Entries 7-9). 
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Table 1: Synthesis of planar-chiral phosphites 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Alcohol 2 3 Phosphites Yield (%) 
1 2a 3a L1 66 
2 2b 3a L2 89 
3 2b 3b L3 56 
4 2b (Sa)-3c (Sa)-L4 98 
5 2b (Ra)-3c (Ra)-L4 ca.80a 
6 2c 3a L2(TMS) 83 
7 2e 3a L2(Ph) 69 
8 2f 3a L2(MeOPh) 58 
9 2g 3a L2 (CF3Ph) 37 
a The total yield of phosphite (Ra)-L4 and monool 2b. 
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Thermal Stability 
 
The thermal stability of paracyclophanyl alcohol 2b was investigated by heating 
in DCE for two hours at different temperatures. An enantiomeric excess of 98% was 
retained even at 60 ˚C. However, it decreased to 88% ee at 80 ˚C. Therefore, 
paracyclophanyl alcohol 2b is sufficiently stable up to 60 ˚C and para-substituted 
paracyclophanyl alcohols 2c and 2e-2g are considered more stable than 2b. 
 
The reactions of paracyclophanyl alcohols and phosphorochloridites were 
performed at room temperature (Table 1), thus, the enantiomeric excess of phosphite 
ligands can be considered equivalent to that of original paracyclophanyl alcohols. 
 
 
Application 
 
These phosphite ligands were employed as chiral ligands in two standard 
reactions: Pd-catalyzed allylic alkylation and Rh-catalyzed 1,4-addition.  
 
Enantioselective allylic alkylation 
 
The author initially investigated the synthesized planar-chiral phosphites in 
enantioselective Pd-catalyzed allylic alkylation (Table 2).6 The reaction between 
dimethyl malonate (4) and (E)-1,3-diphenylallyl acetate (5) proceeded almost 
quantitatively when using phosphite L1 or L2 (Entries 1 and 2). The enantiomeric 
excess of compound 6 was moderate. An observed decrease in the enantiomeric 
excess was probably caused by steric hindrance and the (S)-6 was the major 
enantiomer regardless of the absolute configuration of the axial chirality of the 
phosphite (Entries 4 and 5). Furthermore, the enantiomeric excess was almost the 
same as that obtained using a ligand without axial chirality. These results showed 
that enantioinduction was governed by the planar-chirality of the 1,n-
dioxa[n]paracyclophane scaffold. The author tested para-substituted 
paracyclophanyl phosphites, but the enantioselectivity was not improved (Entries 6-
9). The author further screened the reaction temperature. At lower temperature, the 
enantioselectivity gradually increased and the enantiomeric excess of compound 6 
was 73% at -60 ˚C, albeit in low yield due to the low conversion (Entry 12). But no 
reaction proceeded at -78 ˚C (Entry 13).  
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Table 2: Enantioselective Pd-catalyzed allylic alkylation 
 
 
 
 
  
Entry Phosphite Temp. (˚C) Yield (%)b Ee (%)c 
       1           L1         rt >99       49 (S) 
       2           L2         rt 98       42 (S) 
       3           L3         rt >99        8 (R) 
       4       (Sa)-L4         rt 69       42 (S) 
       5       (Ra)-L4a         rt >99       43 (S) 
       6      L2(TMS)         rt >99       31 (S) 
       7      L2(Ph)         rt >99       33 (S) 
       8      L2(MeOPh)         rt >99       26 (S) 
       9      L2(CF3Ph)         rt >99       43 (S) 
      10          L2           0 >99       55 (S) 
      11          L2        -40 >99       66 (S) 
      12          L2        -60 31       73 (S) 
      13          L2        -78 N.R.        - 
a A mixture of phosphite (Ra)-L4 and monool 2b was used. 
b Isolated yield. c Ee was 
determined by HPLC analysis using Daicel Chiralcel OD-3 (eluent: 1% 2-propanol in hexane, 
flow rate: 0.5 mL/min). The absolute configuration of the major isomer was described in the 
parentheses. 
 
 
Enantioselective Rh-catalyzed 1,4-addition  
The author employed the planar-chiral paracyclophanyl phosphites as chiral 
ligands in Rh-catalyzed 1,4-addition of cyclohex-2-enone (7) with phenylboronic 
acid (8) (Table 3).12 The different structures of phosphites L1 and L2 with different 
ansa chain lengths affected the catalytic activity. With ligand L1 (n=8), the reaction 
did not proceed at all, while with ligand L2, it proceeded with moderate yield and 
enantioselectivity (Entries 1 and 2). Generally, cyclophanes possessing a shorter 
ansa chain are more rigid, namely more bulky. Probably Rh-catalyzed 1,4-addition 
is sensitive to steric bulkiness and more bulky ligand deterred the reaction. With 
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bulky phosphite L3, the reaction did not proceed possibly due to steric hindrance 
(Entry 3). Diastereomers (Sa)-L4 and (Ra)-L4 gave contrasting results (Entries 4 and 
5). While compound 9 was obtained in low yield and enantiomeric excess by using 
(Sa)-L4, no reaction occurred when using (Ra)-L4 probably due to contamination by 
monool 2b. When para-substituted paracyclophanyl phosphites were examined, 
L2(TMS) gave the best enantioselectivity of all the ligands and phenylated product 
9 was obtained in moderate yield (Entries 6-9). 
 
Table 3: Enantioselective Rh-catalyzed 1,4-addition 
 
 
 
 
 
 
Entry Phosphite Yield (%) Ee (%) 
1 L1 NR - 
2 L2 49 36 (S) 
3 L3 NR - 
4 (Sa)-L4 36 16 (S) 
5 (Ra)-L4a NR - 
6 L2 (TMS) 66 40 (S) 
7 L2 (Ph) 18 31 (S) 
8 L2 (MeOPh) 19 37 (S) 
9 L2 (CF3Ph) 67 30 (S) 
                        a A mixture of phosphite (Ra)-L4 and monool 2b was used. a Isolated yield. b Ee was           
determined by HPLC analysis using Daicel Chiralcel OD-3 (eluent: 1% 2-propanol 
in hexane, flow rate: 0.5 mL/min). The absolute configuration of the major isomer 
was described in the parentheses. 
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Enantioselective Induction 
When ligands L1 and L2 possessing only planar-chirality were investigated in Pd-
catalyzed allylic alkylation, moderate enantioselectivity was achieved. Conversely, 
ligands (Sa)- and (Ra)-L4 possessing both planar and axial chiralities exhibited 
almost the same enantioselectivity. Therefore, it can be deduced that the 
enantioselectivity was governed by the planar chirality derived from paracyclophane. 
The axial chirality of the BINOL moiety minimally affected this reaction. Various 
para-substituted planar-chiral ligands were screened and they showed moderate 
enantioselectivity. Ligand L2 showed moderate enantioselectivity for 1,4-addition. 
When (Sa)-L4 was screened, it induced low enantioselectivity. Low 
enantioselectivity was probably due to steric repulsion of paracyclophane moiety 
which was far from the substrate.  Therefore, the enantioselectivity was governed by 
the planar-chirality of paracyclophane. The substituent at the para-position slightly 
affected the enantioselectivity and the highest enantioselectivity was achieved with 
TMS-substituted paracyclophane. 
 
• Conclusion  
 
 The author synthesized planar-chiral paracyclophanes with a hydroxy group 
through enantioselective ortho-lithiation and converted them to paracyclophanyl 
phosphites by reaction with 2,2’-biarylene phosphorochloridites. A ligand library 
was prepared by varying the substituents at the paracyclophane moiety or using 
BINOL and biphenol as backbones. Most of these ligands were stable in air. The 
obtained phosphites were used as chiral ligands in Pd-catalyzed allylic alkylation 
and Rh-catalyzed 1,4-addition.  Moderate enantioselectivity was achieved in both 
reactions and enantioinduction was governed by the planar chirality of 
paracyclophane.  
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• Experimental Section  
General: 1H NMR spectra were recorded on JEOL ECX-500 (500 MHz) 
spectrometers. The chemical shifts were reported in parts per million (δ) relative to 
internal standard TMS (0 ppm) for CDCl3. 13C NMR spectra were obtained by JEOL 
ECX-500 (125 MHz) spectrometers and referenced to the internal solvent signals 
(central peak is 77.16 ppm in CDCl3). CDCl3 was used as a NMR solvent. High-
resolution mass spectra (HRMS) were measured on an ESI (Electro Spray 
Ionization)-Orbitrap mass spectrometer method. Optical rotations were measured on 
a JASCO DIP-1000 polarimeter. IR was measured in JASCO FT/IR-4100ST. 
Preparative thin-layer chromatography (PTLC) was performed with silica gel-
precoated glass plates (Merck 60 GF254) prepared in our laboratory, Flash column 
chromatography was performed over silica gel 200-300. All reactions were 
performed under argon atmosphere. All reagents were purchased from Wako, Kanto, 
Aldrich and TCI and used without further purification. 
Experimental procedure of enantioselective synthesis of paracyclophanes 2b 
A cyclohexane solution of sec-butyllithium (0.99 M, 1 mL, 1.0 mmol) was added 
dropwise to an ethereal solution (5.0 mL) of 1,n-dioxaparacyclophane (n = 11 (1b), 
1.0 mmol) and (+)-sparteine (0.23 mL, 1.0 mmol) at -78 °C and the reaction was 
stirred for 2 h. In another vacuum dried Schlenk tube, dropwise addition of n-BuLi 
(1.54 M, 0.98 ml, 1.5 mmol) to a solution of tert-butyl hydroperoxide (5.5 M, 0.30 
ml, 1.5 mmol) in Et2O (5.0 ml) was carried out at -78 °C and stirred for 30 min. This 
solution was transferred to the previous reaction mixture via cannula and warmed to 
ambient temperature. It was quenched with 1 M HCl (20 ml) aqueous solution and 
extracted with dichloromethane (3×10 ml). The organic layer was washed with brine 
and dried over Na2SO4. It was evaporated under reduced pressure and resultant 
residue was purified through flash column chromatography.  
12-Hydroxy-1,10-dioxa[10]paracyclophane (2a): it was isolated by flash column 
chromatography (hexane/ethyl acetate = 4/1). The title compound was obtained as 
white solid (74.4 mg, 63%). mp 43 °C; IR (CH2Cl2) 3380.6, 2933.2, 2869.6, 1596.8, 
1492.6, 1139.7, 860.1 cm-1; 1H NMR δ 6.94 (d, J = 8.9 Hz, 1H), 6.68 (d, J = 2.7 Hz, 
1H), 6.57 (dd, J = 2.7, 8.9 Hz, 1H), 5.83 (s, 1H), 4.28-4.24 (m, 1H), 4.20-4.12 (m, 
3H), 1.73-1.58 (m, 2H), 1.54-1.46 (m, 1H), 1.39-1.31 (m, 1H), 0.94-0.64 (m, 8H); 
13C NMR δ 155.0, 150.1, 139.7, 120.9, 113.8, 108.9, 73.2, 72.0, 28.2, 28.1, 26.6, 
24.7, 24.5 (A pair of peaks at the aliphatic region is overlapping); HRMS(ESI, 
positive): m/z calcd. for C14H21O3: 237.1485; found: 237.1486; [α]28D = 92.2 (c 0.85, 
CHCl3, 99% ee). Ee was determined by HPLC analysis using a chiral column (Daicel 
Chiralpak IB: 4 x 250 mm, 254 nm UV detector, rt, eluent: 5% 2-propanol in hexane, 
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flow rate: 1.0 mL/min, retention time: 9.1 min for major isomer and 13.7 min for 
minor isomer).  
13-Hydroxy-1,11-dioxa[11]paracyclophane (2b): it was isolated by flash column 
chromatography (hexane/ethyl acetate = 4/1). The title compound was obtained as 
white solid (185.1 mg, 74%). mp 56 °C; IR (CH2Cl2) 3338.2, 2929.3, 2850.3, 1592.9, 
1504.2, 1245.8, 835.0 cm-1; 1H NMR δ 6.95 (d, J = 8.8 Hz, 1H), 6.68 (d, J = 2.9 Hz, 
1H), 6.59 (dd, J = 2.9, 8.8 Hz, 1H), 5.89 (s, 1H), 4.32-4.26 (m, 1H), 4.23-4.12 (m, 
3H), 1.70-1.57 (m, 4H), 1.08-0.78 (m, 10H); 13C NMR δ 156.0, 149.0, 141.0, 119.7, 
112.1, 108.0, 72.5, 71.5, 30.1, 30.1, 27.8, 26.1, 26.0, 25.6, 25.2; HRMS(ESI, 
positive): m/z calcd. for C15H23O3: 251.1642; found: 251.1642; [α]29D = 54.6 (c 0.94, 
CHCl3, 98% ee). Ee was determined by HPLC analysis using a chiral column (Daicel 
Chiralpak IB: 4 x 250 mm, 254 nm UV detector, rt, eluent: 5% 2-propanol in hexane, 
flow rate: 1.0 mL/min, retention time: 8.3 min for major isomer and 13.3 min for 
minor isomer). 
13-Hydroxy-16-(trimethylsilyl)-1,11-dioxa[11]paracyclophane (2c): it was 
isolated by flash column chromatography (hexane/ethyl acetate = 4/1). The title 
compound was obtained as white solid (144.4 mg, 61%). mp 118 °C; IR (CH2Cl2) 
3374.8, 2933.2, 2858.0, 1589.1, 1492.6, 1407.8, 1253.5, 1147.4, 1047.2, 842.7 cm-
1; 1H NMR δ 6.99 (s, 1H), 6.61 (s, 1H), 5.82 (s, 1H), 4.37-4.27 (m, 2H), 4.17-4.07 
(m, 2H), 1.72-1.62 (m, 3H), 1.15-0.79 (m, 10H), 0.72-0.61 (m, 1H), 0.26 (s, 9H); 
13C NMR δ 160.9, 150.1, 140.3, 125.8, 121.2, 104.0, 73.4, 69.5, 30.3, 29.7, 28.1, 
26.8, 26.2, 25.7, 25.3, -0.10; HRMS (ESI, positive): m/z calcd. for C18H30NaO3Si 
(M+Na): 345.1856; found: 345.1857; [α]28D = 54.0 (c 1.00, CHCl3). 
 
13-Hydroxy-16-iodo-1,11-dioxa[11]paracyclophane (2d): it was isolated by flash 
column chromatography (hexane/ethyl acetate = 4/1). The title compound was 
obtained as brown oil (135.5 mg, 80%). IR (CH2Cl2) 3401.8, 2929.3, 2850.3, 1575.6, 
1479.1, 1288.2, 1151.3, 877.5 cm-1; 1H NMR δ 7.37 (s, 1H), 6.69 (s, 1H), 5.84 (s, 
1H), 4.36-4.13 (m, 4H), 1.87-1.55 (m, 4H), 1.11-0.79 (m, 10H); 13C NMR δ 155.1, 
149.3, 142.7, 128.8, 107.6, 78.0, 73.1, 72.2, 30.5, 30.1, 28.2, 26.0, 26.0, 25.6, 24.9; 
HRMS (ESI, positive): m/z calcd. for C15H21INaO3 (M+Na): 399.0428; found: 
399.0429; [α]29D = -0.24 (c 1.17, CHCl3, 97% ee). Ee was determined by HPLC 
analysis using a chiral column (Daicel Chiralpak IB: 4.6×250 mm, 254 nm UV 
detector, rt, eluent: 5% 2-propanol in hexane, flow rate: 1.0 ml/min, retention time: 
11.3 min for major isomer and 17.8 min for minor isomer). 
13-Hydroxy-16-phenyl-1,11-dioxa[11]paracyclophane (2e): it was isolated by 
flash column chromatography (hexane/ethyl acetate = 4/1). The title compound was 
obtained as yellow oil (53.0 mg, 57%). IR (CH2Cl2) 3527.2, 2921.6, 2850.3, 1592.9, 
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1486.9, 1284.4, 1135.9, 902.5, 702.0 cm-1; 1H NMR δ 7.55-7.53 (dd, J = 1.3, 8.4 Hz, 
2H), 7.42-7.39 (m, 2H), 7.32-7.29 (dd, J = 1.3, 7.3 Hz, 1H), 7.04 (s, 1H), 6.78 (s, 
1H), 5.83 (s, 1H), 4.37-4.27 (m, 2H), 3.97-3.92 (m, 1H), 3.71-3.66 (m, 1H), 1.85-
1.61 (m, 2H), 1.52-1.33 (m, 2H), 1.28-0.96 (m, 6H), 0.88-0.71 (m, 4H); 13C NMR δ 
152.1, 147.9, 142.1, 138.4, 129.2, 129.2, 128.2, 128.2, 126.7, 126.6, 120.2, 109.5, 
72.2, 71.0, 30.7, 29.7, 28.0, 26.0, 25.9, 25.6, 25.4; HRMS(ESI, positive): m/z calcd. 
for C21H26NaO3 (M+Na): 349.1774; found: 349.1774; [α]20D = 5.04 (c 1.17, CHCl3, 
96% ee). Ee was determined by HPLC analysis using a chiral column (Daicel 
Chiralpak IB: 4 x 250 mm, 254 nm UV detector, rt, eluent: 5% 2-propanol in hexane, 
flow rate: 1.0 mL/min, retention time: 9.0 min for major isomer and 11.4 min for 
minor isomer). 
13-Hydroxy-16-(4-methoxyphenyl)-1,11-dioxa[11]paracyclophane (2f): it was 
isolated by flash column chromatography (hexane/ethyl acetate = 4/1). The title 
compound was obtained as yellow oil (51.4 mg, 50%). IR (CH2Cl2) 3523.1, 3056.6, 
2921.6, 2850.3, 1589.1, 1504.2, 1461.8, 1232.3, 1143.6, 1101.2, 952.7, 825.4, 694.3, 
644.1 cm-1; 1H NMR δ 7.47 (d, J = 8.8 Hz, 2H), 7.01 (s, 1H), 6.95 (d, J = 8.8 Hz, 
2H), 6.76 (s, 1H), 5.89 (s, 1H), 4.36-4.26 (m, 2H), 3.96-3.91 (m, 1H), 3.85 (s, 3H), 
3.73-3.68 (m, 1H), 1.84-1.60 (m, 2H), 1.52-1.33 (m, 2H), 1.28-0.92 (m, 6H), 0.90-
0.67 (m, 4H); 13C NMR δ 158.5, 151.9, 147.5, 142.1, 130.9, 130.2, 130.2, 126.3, 
120.0, 113.7, 113.7, 109.5, 72.1, 70.9, 55.2, 30.8, 29.7, 28.0, 26.0, 25.9, 25.6, 24.5; 
HRMS(ESI, positive): m/z calcd. for C22H28NaO4 (M+Na): 379.1880; found: 
379.1880; [α]18D = -6.46 (c 1.02, CHCl3). 
13-Hydroxy-16-(4-trifluoromethylphenyl)-1,11-dioxa[11]paracyclophane (2g): 
it was isolated by flash column chromatography (hexane/ethyl acetate = 4/1). The 
title compound was obtained as yellow oil (66.2 mg, 54%). IR (CH2Cl2) 3380.6, 
2933.2, 2865.7, 1618.0, 1504.2, 1330.6, 1126.22, 846.6, 729.0 cm-1; 1H NMR δ 7.65 
(s, 4H), 7.05 (s, 1H), 6.80 (s, 1H), 5.88 (s, 1H), 4.39-4.27 (m, 2H), 4.04-3.98 (m, 
1H), 3.76-3.70 (m, 1H), 1.82-1.61 (m, 2H), 1.51-1.33 (m, 2H), 1.26-0.68 (m, 10H); 
13C NMR δ 152.4, 148.7, 142.2, 142.0, 129.4, 129.4, 128.6 (q, J = 32.48 Hz), 125.2, 
125.1, 125.1, 120.1, 109.2, 72.3, 71.4, 30.7, 29.7, 27.9, 26.0, 25.9, 25.5, 24.5 (A 
peak derived from CF3 is missing); 19F NMR δ -62.09; HRMS(ESI, positive): m/z  
calcd. for C22H25F3NaO3 (M+Na): 417.1648; found: 417.1647; [α]19D = 16.9 (c 0.67, 
CHCl3). 
Typical experimental procedure for the synthesis of phosphite ligands (L1 –L4):  
To a THF (1.5 ml) solution of alcohol 2a (0.15 mmol), triethylamine (0.45 mmol) 
and 2,2’-biarylene phosphorochloridite 3 (prepared by mixing the corresponding 
biaryl diol (0.20 mmol) and PCl3 (0.28 mmol) at 75 °C for overnight) were added 
and stirred at room temperature for overnight. The resulting solution was filtered 
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through filter paper using dichloromethane and was evaporated to dryness at room 
temperature.  
6-(1,10-Dioxa[10]paracyclophan-12-
yloxy)dibenzo[d,f][1,3,2]dioxaphosphepine (L1): it was isolated by Florisil® 
column chromatography (hexane/ethyl acetate = 4/1). The title compound was 
obtained as colorless oil (44.6 mg, 66%). IR (CH2Cl2) 2933.2, 2858.0, 1602.6, 
1504.2, 1249.7, 1186.0, 1151.3, 1097.3, 906.4, 860.1 cm-1; 1H NMR δ 7.49 (dd, J = 
1.8, 8.1 Hz, 2H), 7.41-7.36 (m, 2H), 7.32-7.28 (m, 3H), 7.21 (d, J = 7.7 Hz, 1H), 
7.07 (d, J = 9.3, 1H), 6.86 (d, J = 1.8 Hz, 1H), 6.78 (dd, J = 2.7, 8.6 Hz, 1H), 4.34-
4.20 (m, 2H), 4.18-4.10 (m, 2H), 1.60-1.49 (m, 4H), 0.93-0.48 (m, 8H); 13C NMR δ 
154.4, 149.2 (d, J = 5.0 Hz), 149.0 (d, J = 4.8 Hz), 145.3 (d, J = 6.5 Hz), 143.5, 
143.4, 131.3 (d, J = 3.8 Hz), 131.1 (d, J = 2.6 Hz), 129.9, 129.2, 125.5 (d, J = 1.0 
Hz), 125.3 (d, J = 1.2 Hz), 123.8, 122.3 (d, J = 1.7 Hz), 122.2 (d, J = 1.2 Hz), 117.3 
(d, J = 1.4 Hz),115.0, 115.0, 72.4, 71.4, 28.3, 27.3, 26.4, 26.3, 24.9, 23.7; 31P NMR 
(200 MHz) δ 147.9; HRMS(ESI, positive): m/z calcd. for C26H27NaO5P (M+Na): 
473.1488; found: 473.1490; [α]26D = 20.4 (c 0.92, CHCl3).  
6-(1,11-Dioxa[11]paracyclophan-13-
yloxy)dibenzo[d,f][1,3,2]dioxaphosphepine (L2): it was isolated by Florisil® 
column chromatography (hexane/ethyl acetate = 4/1). The title compound was 
obtained as colorless oil (62.8 mg, 89%). IR (CH2Cl2) 2929.3, 2858.0, 1598.7, 
1496.5, 1432.9, 1238.1, 1147.4, 1093.4, 910.2, 867.8 cm-1; 1H NMR δ 7.50 (dd, J = 
2.0, 8.0 Hz, 2H), 7.41-7.36 (m, 2H), 7.33-7.28 (m, 3H), 7.21 (d, J = 8.0 Hz, 1H), 
7.08 (d, J = 8.0 Hz, 1H), 6.87 (dd, J = 1.0, 2.8 Hz, 1H), 6.84-6.81 (m, 1H), 4.36-4.26 
(m, 1H), 4.24-4.10 (m, 3H), 1.74-1.55 (m, 4H), 1.12-0.76 (m, 10H); 13C NMR δ 
156.1, 149.2, 149.1, 149.0, 149.0, 144.7 144.7 (d, J = 1.0 Hz), 130.0 (d, J = 1.2 Hz), 
129.2 (d, J = 1.2 Hz), 125.4 (d, J = 1.2 Hz), 125.3 (d, J = 1.2 Hz), 123.2, 122.3 (d, J 
= 1.2 Hz), 122.2 (d, J = 1.2 Hz), 116.5, 116.5 114.2, 114.1, 72.1, 71.5, 30.2, 29.6, 
27.7, 26.1, 26.0, 25.9, 25.2; 31P NMR (200 MHz) δ 146.5; HRMS(ESI, positive): 
m/z calcd. for C27H29NaO5P (M+Na): 487.1645; found: 487.1645;[α]26D= 30.8 (c 
1.30, CHCl3).  
6-(1,11-Dioxa[11]paracyclophan-13-yloxy)-2,4,8,10-
tetramethyldibenzo[d,f][1,3,2]dioxaphosphepine (L3): it was isolated by 
Florisil® column chromatography (hexane/ethyl acetate = 4/1). The title compound 
was obtained as colorless oil (43.7 mg, 56%). IR (CH2Cl2) 2950.6, 2896.6, 1745.3, 
1483.0, 1245.8, 1211.1, 1151.3, 1037.5, 833.1 cm-1; 1H NMR δ 7.12-7.07 (m, 4H), 
6.84-6.79 (m, 3H), 4.33-4.28 (m, 1H), 4.21-4.09 (m, 3H), 2.44 (s, 3H), 2.41 (s, 3H), 
2.37 (d, J = 3.4, 6H), 1.72-1.61 (m, 4H), 1.09-0.79 (m, 10H); 13C NMR δ 156.2, 
145.4 (d, J = 5.4 Hz), 144.7 (d, J = 3.2 Hz), 134.4 (d, J = 3.3 Hz), 134.2 (d, J = 1.2 
 
 
37 
Hz), 131.6 (d, J = 3.9 Hz), 131.3, 131.2, 131.0 (d, J = 2.7 Hz), 130.5 (d, J = 2.0 Hz), 
130.2 (d, J = 1.2 Hz), 128.2 (d, J = 1.2 Hz), 128.1 (d, J = 1.2 Hz), 123.3, 116.2, 
113.9, 113.8, 72.5, 71.6, 30.4, 29.6, 27.9, 26.4, 26.3, 26.1, 25.4, 21.0 (d, J = 1.2 Hz), 
17.1, 16.8; 31P NMR (200 MHz) δ 144.9; HRMS(ESI, positive): m/z calcd. for 
C31H37NaO5P (M+Na): 543.2271; found: 543.2272; [α]26D = 3.56 (c 1.26, CHCl3). 
4-(1,11-Dioxa[11]paracyclophan-13-yloxy)dinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepine ((Sa)-L4): it was isolated by Florisil® column 
chromatography (hexane/ethyl acetate = 4/1). The title compound was obtained as 
foamy white solid (100.8 mg, 98%). mp 90 °C; IR (CH2Cl2) 2929.3, 2850.3, 1592.9, 
1500.4, 1465.6, 1232.3, 1189.9, 1151.3, 952.7, 838.9, 740.5, 702.0 cm-1; 1H NMR δ 
8.00-7.91 (m, 4H), 7.55 (dd, J = 9.1, 9.1 Hz, 2H), 7.47-7.38 (m, 4H), 7.30-7.24 (m, 
2H), 7.07 (d, J = 8.6 Hz, 1H), 6.88-6.81 (m, 2H), 4.33- 4.28 (m, 1H), 4.21-4.15 (m, 
3H), 1.72-1.59 (m, 4H), 1.05-0.78 (m, 10H); 13C NMR δ 156.0, 147.8 (d, J = 4.6 
Hz), 147.0 (d, J = 2.4 Hz), 144.8 (d, J = 2.9 Hz), 144.7, 144.6, 132.8 (d, J = 1.7), 
132.6 (d, J = 1.7 Hz), 131.6, 131.3, 130.4, 129.7, 128.4, 128.3, 127.1, 127.0, 126.3, 
126.1, 125.2, 125.0, 123.2, 122.1, 121.8 (d, J = 1.7), 116.6, 114.1, 114.1, 72.1, 71.5, 
30.2, 29.6, 27.7, 26.2, 26.0, 25.9, 25.2; 31P NMR (200 MHz) δ 148.9; HRMS(ESI, 
positive): m/z calcd. for C35H33NaO5P (M+Na): 587.1958; found: 587.1957; [α]25D 
= 175.9 (c 0.68, CHCl3). 
4-(1,11-Dioxa[11]paracyclophan-13-yloxy)dinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepine ((Ra)-L4): the compound was obtained as a mixture of 
(Ra)-L4 and 2b, and could not be isolated because of its instability. The title 
compound was obtained as foamy white solid (85.1 mg, ca. 80%). Mp 70 °C; IR 
(CH2Cl2) 3396.0, 2935.1, 2858.0, 1567.8, 1486.9, 1280.5, 1189.9, 1151.3, 902.5, 
771.4 cm-1; 1H NMR δ 8.01-7.96 (m, 4H), 7.60-6.57 (m, 11H), 4.35- 4.12 (m, 4H), 
1.72-1.55 (m, 4H), 1.09-0.76 (m, 10H); 13C NMR δ 156.0, 147.8 (d, J = 4.6 Hz), 
147.0 (d, J = 2.4 Hz), 144.8 (d, J = 2.9 Hz),144.7, 144.6, 132.8 (d, J = 1.7 Hz), 132.6 
(d, J = 1.7 Hz), 131.6, 131.3, 130.4, 129.7, 128.4, 128.3, 127.1, 127.0, 126.3, 126.1, 
125.2, 125.0, 123.2, 122.1, 121.8 (d, J = 1.7 Hz), 116.6, 114.1, 114.1, 72.1, 71.5, 
30.2, 29.6, 27.7, 26.2, 26.0, 25.9, 25.2; 31P NMR (200 MHz) δ 1467.3; HRMS(ESI, 
positive): m/z calcd. for C35H33NaO5P (M+Na): 587.1958; found: 587.1959;  
6-(16-(Trimethylsilyl)-1,11-dioxa[11]paracyclophan-13-
yloxy)dibenzo[d,f][1,3,2]dioxaphosphepine (L2(TMS)): it was isolated by 
Florisil® column chromatography (hexane/ethyl acetate = 4/1). The title compound 
was obtained as colorless oil (67.0 mg, 83%). IR (CH2Cl2) 2925.5, 2865.7, 1606.4, 
1500.4, 1429.0, 1429.7, 1193.7, 1157.1, 1087.7, 970.0, 910.2, 860.1, 740.5 cm-1; 1H 
NMR δ 7.51-7.28 (m, 7H), 7.22-7.20 (m, 1H), 7.12 (m, 1H), 6.77 (s, 1H), 4.35-4.29 
(m, 2H), 4.20-4.11 (m, 2H), 1.78-1.45 (m, 4H), 1.11-0.57 (m, 10H), 0.29 (s, 9H); 
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13C NMR δ 160.7, 149.1 (dd, J = 4.8, 11.6 Hz), 145.5 (d, J = 6.0 Hz), 143.2 (d, J = 
3.3 Hz), 131.3 (d, J = 3.3 Hz), 131.2 (d, J = 3.0 Hz), 130.0, 130.0, 129.2, 129.1, 
129.1, 126.2 (d, J = 1.2 Hz), 125.4, 125.3, 122.4 (d, J = 1.5 Hz), 122.2 (d, J = 1.2 
Hz), 110.0, 110.0, 72.3, 69.6, 29.6, 29.5, 27.8, 26.5, 26.5, 26.2, 24.7, -0.4; 31P NMR 
(200 MHz) δ 146.3; HRMS(ESI, positive): m/z calcd. for C30H37INaO5PSi (M+Na): 
559.2040; found: 559.2040; [α]25D = 23.3 (c 0.66, CHCl3). 
6-(16-Phenyl-1,11-dioxa[11]paracyclophan-13-
yloxy)dibenzo[d,f][1,3,2]dioxaphosphepine (L2(Ph)): it was isolated by Florisil® 
column chromatography (hexane/ethyl acetate = 4/1). The title compound was 
obtained as colorless oil (56.0 mg, 69%). IR (CH2Cl2) 2925.5, 2854.1, 1606.4, 
1490.7, 1442.4, 1241.9, 1178.3, 1139.7, 1033.7, 910.2, 835.0, 769.5, 736.7, 702.0, 
599.8, 516.8 cm-1; 1H NMR δ 7.57-7.50 (m, 4H), 7.45-7.24 (m, 9H), 7.18 (s, 1H), 
6.98 (s, 1H), 4.42-4.26 (m, 2H), 4.00-3.78 (m, 2H), 1.90-1.63 (m, 2H), 1.49-1.33 (m, 
2H), 1.11-0.74 (m, 10H); 13C NMR δ152.2, 149.2 (d, J =4.9 Hz), 149.0 (d, J = 4.9 
Hz), 145.5 (d, J = 3.3 Hz), 143.4 (d, J = 5.8 Hz), 137.9, 131.3 (d, J = 3.0 Hz), 131.1 
(d, J = 2.7 Hz), 130.9, 130.3, 130.2, 130.0, 129.3, 129.2, 128.3, 127.1, 126.8, 125.5, 
125.3, 123.7, 122.4, 122.2, 121.7 (d, J = 4.0 Hz), 115.7 (d, J = 6.4 Hz), 71.9, 71.4, 
30.1, 29.9, 27.8, 26.1, 26.0, 25.6, 25.3; 31P NMR (200 MHz) δ 144.9; HRMS(ESI, 
positive): m/z calcd. for C33H33NaO5P (M+Na): 563.1958; found: 563.1959; [α]21D 
= 10.3 (c 0.69, CHCl3).  
6-(16-(4-Methoxyphenyl)-1,11-dioxa[11]paracyclophan-13-
yloxy)dibenzo[d,f][1,3,2]dioxaphosphepine (L2(MeOPh)): it was isolated by 
Florisil® column chromatography (hexane/ethyl acetate = 4/1). The title compound 
was obtained as colorless oil (33.0 mg, 58%). IR (CH2Cl2) 2929.3, 2854.1, 1619.9, 
1500.4, 1245.8, 1178.3, 1132.0, 1066.4, 907.0, 838.9, 769.5 cm-1; 1H NMR δ 7.52-
7.23 (m, 10H), 7.15 (s, 1H), 7.07-6.94 (m, 3H), 4.41-4.25 (m, 2H), 3.86 (s, 3H), 
3.99-3.67 (m, 2H), 1.87-1.33 (m, 4H), 0.74-1.10 (m, 10H); 13C NMR δ 158.9, 152.2, 
149.3 (d, J = 5.0 Hz), 149.2 (d, J = 4.8 Hz), 145.7 (d, J = 2.9 Hz), 143.1 (d, J = 6.0 
Hz), 131.5, 131.5, 131.3, 131.3, 130.7 (d, J = 1.2 Hz), 130.5, 130.4, 130.1 (d, J = 1.4 
Hz), 129.4, 129.3, 125.6 (d, J = 0.96 Hz), 125.5, 123.5, 122.5 (d, J = 1.4 Hz), 122.4 
(d, J = 1.2 Hz), 115.9, 115.9, 113.9, 113.8, 72.0, 71.4, 55.4, 30.3, 30.1, 28.0, 26.2, 
26.1, 25.7, 25.4; 31P NMR (200 MHz) δ 147.6; HRMS(ESI, positive): m/z calcd. for 
C34H35NaO6P (M+Na): 593.2063; found: 593.2063; [α]26D = 2.21 (c 0.71, CHCl3).  
6-(16-(4-(Trifluoromehtyl)phenyl)-1,11-dioxa[11]paracyclophan-13-
yloxy)dibenzo[d,f][1,3,2]dioxaphosphepine (L2(CF3Ph)): it was isolated by 
Florisil® column chromatography (hexane/ethyl acetate = 4/1). The title compound 
was obtained as colorless oil (33.4 mg, 37%). IR (CH2Cl2) 2929.3, 2850.3, 1490.7, 
1241.9, 1211.1, 1147.4, 1101.2, 885.2, 864.0, 813.8 cm-1; 1H NMR δ 7.68-7.65 (m, 
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4H), 7.53-7.17 (m, 8H), 7.17-6.79 (m, 2H), 4.42-4.26 (m, 2H), 4.05-3.70 (m, 2H), 
1.88-1.64 (m, 2H), 1.50-1.32 (m, 2H), 1.20-0.71 (m, 10H); 13C NMR δ 152.5, 149.2, 
149.0 (d, J = 5.2 Hz), 145.5 (d, J = 2.4 Hz), 144.3, 144.3, 141.4, 131.3 (d, J = 3.1 
Hz), 131.1 (d, J = 2.2 Hz), 130.0, 129.6, 129.2, 125.5, 125.4, 125.2, 125.2, 123.6, 
122.3, 122.2, 115.5, 115.4, 72.0, 71.7, 30.0, 29.8, 27.8, 26.1, 26.0, 26.0, 25.6, 25.2 
(A peak derived from CF3 is missing); 31P NMR (200 MHz) δ 144.5; 19F NMR (470 
MHz) δ -62.2; HRMS(ESI, positive): m/z calcd. for C34H32F3NaO5P (M+Na): 
631.1832; found: 631.1829; [α]23D = 19.0 (c 0.67, CHCl3).  
Experimental procedure for enantioselective alkylation in Table 2 
In a schlenk tube, [Pd(allyl)Cl]2 catalyst (2.0 mol%) and the ligand (8.0 mol%) was 
dissolved in DCM (0.9 ml) and stirred for 40 min at the desired temperature. (E)-
1,3-Diphenylallyl acetate (5) (0.03ml, 0.15mmol) was added and stirred for another 
15 min. Dimethyl malonate (4) (0.03ml, 1.8 equiv) was added followed by addition 
of BSA (1.3 equiv) and KOAc (1.3 equiv), then stirred at the desired temperature for 
24-48 h. The reaction mixture was diluted by DCM, filtered and evaporated. The 
crude mixture was purified by PTLC. The absolute configuration of product 6 was 
determined by comparison of the sign of optical rotation with that in the literature.13 
Experimental procedure for 1,4-addition in Table 3 
In a schlenk tube, Rh catalyst (1.8 mol%) and the ligand (7.2 mol%) was added 
followed by addition of cyclohex-2-enone (7) (9.7 µl, 0.1 mmol), phenylboronic acid 
(8) (12.8mg, 1.05 equiv) and stirred for 5 min. Et3N (1.0 mol%) was added followed 
by addition of dioxane/H2O (8/1) and stirred at room temperature for 72 h. The 
reaction mixture was evaporated and crude product was purified by PTLC. The 
absolute configuration of product 9 was determined by comparison of the sign of 
optical rotation with that in the literature.14 
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Chapter 3 
Synthesis of Planar-Chiral Paracyclophanyl 
Phosporamidite Ligands and Their Application to 
Asymmetric Reactions 
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• Background 
 Asymmetric catalysis with transition metal complexes is a basis for extensive 
stereoselective transformations. Its success lies in the design of vital chiral ligands. 
Chiral ligand design involves inexpensive ligands and catalysts that are easily 
prepared and allow fine tuning for specific chemical transformations. There is a high 
demand for expansion of the catalytic tool box and for catalysts that can be optimized 
for enantioselective synthetic steps that avoid tedious procedures. Another important 
issue is practicability. During the past few decades, most studies relied on 
multidentate chiral ligands. The bidentate chiral ligand DIOP developed by Kagan 
and Dang in 1971 began the era of bidentate ligands. Following its commercial 
success in L-DOPA synthesis, the superiority of bidentate ligands was established. 
During these years, many applications of monodentate ligands emerged. 
Monodentate chiral phosphoramidites were then introduced in 1994.1 In 1996/1997, 
a vital breakthrough appeared in the synthesis of asymmetric copper-catalyzed 
conjugate addition with high enantioselectivity.2 This was the start of the new 
millennium for monodentate chiral ligands. During the last decade, various 
asymmetric transformations were found to work well with monodentate chiral 
ligands. The research groups of Reetz, Pringle, Feringa and deVries independently 
reported using monodentate phosphoramidite ligands for hydrogenation attaining 
high enantioselectivity. Phosphoramidites offered excellent and versatile 
performances in asymmetric hydrogenation. Phosphoramidites were easily prepared 
by reaction with the appropriate amine in the presence of base. They are extremely 
stable and versatile, and allow rapid fine-tuning by varying the substituents. 
Examples of  chiral phosphoramidite ligands 
Chiral phosphoramidite ligands have been used in several reactions including 
hydrogenation, allylic alkylation, and conjugate addition. 
The most often studied and effective transition metal-catalyzed reactions is the 
enantioselective hydrogenation of functionalized prochiral olefins. Here, 
monodentate phosphoramidites are reported as new ligands for enantioselective Rh-
catalyzed olefin hydrogenation (Scheme 1).3 
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Scheme 1: Rh-catalyzed asymmetric hydrogenation 
 
Conjugate addition of organometallic reagents to ,-unsaturated systems is a key 
transformation in synthetic organic chemistry. The enantioselective 
Cu/phosphoramidite-catalyzed 1,4-addition of dialkylzinc reagents to acyclic 
dienones is described. The obtained product can be further functionalized by a 
second conjugate addition, but with modest diastereoselectivity (Scheme 2).4 
 
 
 
 
 
 
 
 
Scheme 2: Cu-catalyzed conjugate addition 
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Feringa et al. disclosed Cu-catalyzed allylic substitution with phosphoramidite as 
ligand in 2001. They described asymmetric allylic alkylation of cinnamyl halides 
with dialkylzinc reagents. Although the branched/linear ratio and yields were 
moderate, the branched product exhibited 77% ee (Scheme 3).5 
 
 
 
 
 
Scheme 3: Cu-catalyzed allylic alkylation 
 
Zhou et al. described a Rh-catalyzed enantioselective intramolecular Pauson-
Khand reaction employing a chiral monophosphoramidite. In this reaction, an in situ  
catalyst obtained from [Rh(CO)2Cl]2, SIPHOS, the spiro-monophosphoramidite 
ligand and AgSbF6 was found productive for a series of 1,6-enynes affording the 
cocyclized products with good enantiomeric excess (Scheme 4).6 
   
 
 
 
 
 
Scheme 4: Rh-catalyzed enantioselective Pauson-Khand reaction 
 Rh-catalyzed hydroboration presents a extremely versatile method for 
enantioselective functionalization of olefins. A Rh/phosphoramidite-catalyzed 
hydroboration of styrenes with pinacolborane was reported by Takacs et al.7 By 
employing TADDOL-derived phosphoramidites possessing a sterically crowded 
amine moiety, the corresponding chiral benzyl alcohols were achieved with 
excellent yields and enantiomeric excess after oxidation. Although, it was found that 
only moderate to good regioselectivity was achieved (Scheme 5). 
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Scheme 5: Rh-catalyzed asymmetric hydroboration of styrenes 
Purpose of this chapter 
      As mentioned above, phosphoramidites have rapidly emerged as highly potent 
ligands in enantioselective transition metal catalysis. Their versatility is arguably 
evident from their numerous reactions. The most attractive feature of this type of 
ligand is that they are easily accessible from cheap starting materials, and thus their 
structures can be readily optimized for specific transformations. 
They are easily prepared by reacting with the appropriate amine in the presence 
of base. They are extremely versatile and allow rapid fine tuning by varying their 
substituents. Therefore, a library of ligands can be easily prepared for specific 
transformations. They are also extremely stable. Thus, the author describes the 
synthesis of chiral phosphoramidites in Fig.1. 
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Fig. 1: Outline synthesis of phosphoramidites 
The obtained phosphoramidites were used in benchmark reactions such as allylic 
substitution and conjugate addition to test their efficiency.  
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• Results and Discussion 
Synthesis of planar-chiral paracyclophanylamine 
 The author synthesized a new family of chiral phosphoramidite ligands via three 
steps. In the presence of (+)-sparteine, enantioselective ortho-lithiation8 of 1,11-
dioxa[11]paracyclophane (1)  was performed, subsequent quenching with 
trimethylsilylmethyl azide9 then furnished planar-chiral paracyclophanylamine 2 in 
excellent enantiomeric excess. (Scheme 6). 
 
 
 
 
Scheme 6: Synthesis of planar-chiral paracyclophanylamine 
The planar chirality of primary amine 2 was exploited in the reductive amination 
of carbonyl compounds with sodium triacetoxyborohydride, which furnished 
secondary paracyclophanylamines 3a-3c (Scheme 7).  
 
 
 
 
 
 
 
Scheme 7: Synthesis of secondary paracyclophanylamines 
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Moreover, the planar-chirality of aldehyde 410 was used for reductive amination 
by benzylamine and isopropylamine under the reaction conditions described above 
to give secondary paracyclophanylmethylamines 5a and 5b (Scheme 8). The 
retention of enantiomeric excess of the reductive amination was established by 
compounds 3a and 5a (Scheme 8). 
 
 
 
 
 
 
Scheme 8: Synthesis of secondary paracyclophanylmethylamines 
 
Thermal stability 
        The thermal stabilities of paracyclophanylamines and 
paracyclophanylmethylamines were determined. Paracyclophanylamines were 
slightly more stable than paracyclophanylmethylamines under heated conditions. At 
room temperature, the ee of 3a was measured as 98%. After heating 3a in DCE 
solvent for two hours at 40 ˚ C, the ee decreased only slightly to 97%. However, when 
it was heated at 60 ˚C for two hours, the enantioselectivity decreased to 89%. 
Therefore, paracyclophanylamines can tolerate heating up to 40 ˚C but destabilize at 
60 ˚C. However, when the author heated 5a for two hours at 40 ˚C, the ee decreased 
to 72% from 97% at room temperature. Therefore, paracyclophanylmethylamines 
cannot withstand heating at even 40 ˚C. Thus, based on the ee decreases, 
paracyclophanylamines are more stable than paracyclophanylmethylamines.   
The reaction of paracyclophanylamines and paracyclophanylmethylamines with 
phosphorochloridites were performed at -78 °C to room temperature; thus, the 
enantiomeric excess of phosphoramidite ligands can be considered equivalent to that 
of original paracyclophanylamines and paracyclophanylmethylamines. 
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Synthesis of phosphoramidites  
With n-butyllithium, lithiation of these secondary amines in the presence of 
TMEDA proceeded, and this was followed by treatment with in situ prepared 2,2’-
biarylene phosphorochloridites (Scheme 9). n-Butyllithium was added in slightly 
excess amount because starting material was not consumed completely. The reaction 
of paracyclophanylamine 3a with axially chiral 2,2’-binaphthyl 
phosphorochloridites afforded the corresponding (Ra)-L1 and (Sa)-L1. These ligands 
have both planar and axial chiralities. Diastereomeric (Ra)-L2 and (Sa)-L2 were 
obtained from paracyclophanylmethylamine 5a. These ligands also exhibited planar 
and axial chiralities. The N-methyl and N-isopropyl counterparts (Ra)-L3 and (Ra)-
L4 were also synthesized from 3b and 3c. When 3a, 5a, and 5b were reacted with 
achiral 2,2’-biphenylene phosphorochloridite, L5-L7 were obtained. The retention 
of enantiomeric excess of L6 was ascertained. L8 and L9, i.e, tetramethyl-
substituted biphenylene-derived ligands were also synthesized using a similar 
procedure to that described above. These phosphoramidites were purified by silica 
gel preparative chromatography to afford foamy solids, which were stable at room 
temperature; therefore, due to their ease of handling, they could easily be applied to 
catalytic asymmetric reactions.  
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Scheme 9: Synthesis of phosphoramidites 
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After synthesizing these planar-chiral phosphoramidites, ligands L1-L9 were 
employed in two standard reactions, Pd-catalyzed allylic substitution and Cu-
catalyzed conjugate addition. 
Pd-catalyzed allylic substitution  
The author conducted enantioselective allylic alkylation reaction according to (Table 
1).11 The allylated product 8 was obtained by reacting dimethyl malonate (7) with 
(E)-1,3-diphenylallyl acetate (6) in low to excellent yield. Variations in 
stereoselectivity and enantioselectivity were observed depending on the ligand 
structure. Initially, temperature screening was performed with the (Sa)-L2 ligand 
(Table 1).  
 
Table 1: Enantioselective Pd-catalyzed allylic alkylation of malonate 
 
 
 
 
 
 
 
  Entry     Temp.(˚C)    Yield (%)a       Ee  (%)b 
     1           rt        90       22 (R) 
     2         -20        73       21 (R) 
     3         -40        77       32 (R) 
     4         -60        74       67 (R) 
     5         -78        N.R.        - 
                  a Isolated yield. b Ee was determined by HPLC analysis using Daicel Chiralcel 
OD-3 (eluent: 1% 2-propanol in hexane, flow rate: 0.5 mL/min). The absolute 
configuration of the major isomer was described in the parentheses. 
 
 
 The highest enantioselectivity was obtained at -60 ˚ C. Thus, all the reactions were 
conducted at -60 ˚C (Table 2). The major enantiomer (R)-8 was obtained from the 
diastereomeric pair (Ra)-L1 and (Sa)-L1, which contain both planar and axial 
chiralities. These results indicate that the stereoselectivity was mainly determined 
by the planar-chiral paracyclophane moiety (Entries 1 and 2). However, the BINOL 
moiety was also important for enantioselective induction, as phosphoramidite 
ligands L5 and L8, obtained from 2,2’-biphenol and tetramethyl-substituted 2,2’-
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biphenol backbones, afforded low enantioselectivity (Entries 7 and 10). Conversely, 
the diastereomeric pair, paracyclophanylmethylamine-based (Ra)-L2 and (Sa)-L2, 
showed opposite stereoselectivities, indicating that the axial chirality of the BINOL 
backbone predominantly controlled the stereoselectivity. (Entries 3 and 4). Notably, 
ligand L6 possessing only planar chirality showed the highest enantioselectivity of 
70%. Furthermore, L7 and L9, i.e, paracyclophanylmethylamine-based ligands, 
resulted in low enantioselectivities due to steric bulkiness (Entries 9 and 11). These 
results indicate that in the phosphoramidite ligand, the planar-chiral 
dioxaparacyclophane was an effective chiral scaffold. The choice of substituent on 
the nitrogen atom and the 2,2’-biphenylene diol backbone were also important. 
  
Table 2: Enantioselective Pd-catalyzed allylic alkylation of malonate 
 
 
 
 
 
 
 
Entry Ligand Yield (%)a Ee (%)b 
      1        (Ra)-L1         49 48 (R) 
      2        (Sa)-L1         76 39 (R) 
      3        (Ra)-L2         75 62 (S) 
      4        (Sa)-L2         74 67 (R) 
      5        (Ra)-L3         81 12 (S) 
      6        (Ra)-L4         36 10 (R) 
      7           L5         97 6 (R) 
      8           L6         82 70 (R) 
      9           L7         86 51 (R) 
     10           L8         23 15 (R) 
     11           L9         50 8 (R) 
                  a Isolated yield. b Ee was determined by HPLC analysis using Daicel Chiralcel 
OD-3 (eluent: 1% 2-propanol in hexane, flow rate: 0.5 mL/min). The absolute 
configuration of the major isomer was described in the parentheses. 
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Cu-catalyzed conjugate addition 
 
 The author studied ligands L1-L9 in Cu-catalyzed asymmetric conjugate addition 
of chalcone (9) with diethylzinc.12 The ethylated product 10 was afforded in 
moderate to quantitative yield (Table 3). Contrary to the Pd-catalyzed allylic 
alkylation, the opposite enantiomers of the alkylated product 10 were obtained from 
the diastereomeric pair (Ra)-L1 and (Sa)-L1 and the enantioselectivity was 
completely different (Entries 1 and 2). Low enantioselectivity was observed on 
treating with the diastereomeric pair of paracyclophanylmethylamine-based ligands, 
(Ra)-L2 and (Sa)-L2 (Entries 3 and 4). The potential for a substituent on the nitrogen 
atom was important as the methyl group showed the best enantioselectivity of 64% 
among paracyclophanylamine-based ligands containing BINOL as a backbone 
(Entries 1, 5 and 6). Conversely, with the ligand having an achiral 2,2’-biphenol as 
a backbone, moderate enantioselectivity was induced by an isopropyl group on the 
nitrogen atom (Entries 5-9). Thus, a slight change in the structure of the 
phosphoramidite ligands resulted in a different degree of enantioselective induction 
by the cooperative effect of three substituents at the nitrogen center.  
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Table 3: Enantioselective Cu-catalyzed conjugate addition 
 
 
 
 
   Entry      Ligand    Time (h)   Yield (%)a Ee (%)b 
       1        (Ra)-L1         1.5       >99 44 (R) 
       2        (Sa)-L1         1.0       >99 18 (S) 
       3        (Ra)-L2         3.0       >99 6 (S) 
       4        (Sa)-L2         1.0       >99 17 (R) 
       5        (Ra)-L3         1.5         91 64 (R) 
       6        (Ra)-L4          2.0       >99 7 (S) 
       7            L5         3.0       >99 4 (R) 
       8            L6         5.5         70 19 (R) 
       9            L7         1.5         89 50 (R) 
      10            L8         5.5         88 14 (R) 
      11            L9         5.5         63 4 (R) 
a Isolated yield. b Ee was determined by HPLC analysis using Daicel Chiralcel OD-3 (eluent: 0.5% 2-
propanol in hexane, flow rate: 1.0 mL/min). The absolute configuration of the major isomer was described 
in the parentheses. 
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Control experiment without planar chirality 
 
When ligand (Ra)-L10 with no planar-chiral paracyclophane moiety was used in 
a Cu-catalyzed conjugate addition, not only the yield but also the enantioselectivity 
decreased. This highlights the importance of the planar chiral paracyclophane 
moiety in enantioinduction. 
 
 
 
 
 
 
 
 
 
Scheme 10: Control Experiment 
 
Cooperative effect of chiralities 
 
The cooperative effect of chiralities was observed in a conjugate addition reaction. 
When a ligand containing either axial or planar chirality was used, a decrease in 
enantioselectivity was observed (Entry 7 and scheme 10). However, when a ligand 
possessing both axial and planar chirality was used, the enantioselectivity was good 
(Entry 5). This illustrates the cooperative effect of both planar and axial chirality. 
The structure of the amine moiety is crucial, but the BINOL also significantly 
influenced the enantioinduction. Because of steric repulsion, the paracyclophane 
moiety was far from the substrate. This was confirmed by the low enantiomeric 
excess of ligand containing only planar chirality (Entry 7). There are no reports 
describing the enantioinduction mechanism. A matched-mismatched combination 
may occur. In addition to the BINOL backbone, the choice of substituents at the 
nitrogen center was also important. The cooperative effect of three substituents at 
the nitrogen center was important for enantioselective induction. 
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• Conclusion 
 
A chiral library of phosphoramidite ligands was synthesized with planar chirality 
on the nitrogen atom. These were easily prepared with the appropriate amines in the 
presence of base. Substituents at the nitrogen atom were varied. BINOL and 
biphenol backbone were employed. A combination of planar and axially chiral 
ligands was synthesized. Their efficiency was examined in two well-known 
reactions, Pd-catalyzed allylic alkylation and Cu-catalyzed conjugate addition. 
These ligands are easy tuned and easy to handle. Therefore, they are not difficult to 
preserve. They are also moisture stable. They afforded moderate to good 
enantioselectivity in Pd-catalyzed allylic alkylation and Cu-catalyzed conjugate 
addition. The cooperative effect of both planar and axial chiralities was examined in 
copper-catalyzed conjugate addition. 
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• Experimental Section  
 
General 
Unless otherwise noted, all materials were purchased from commercial suppliers 
and used as received. Anhydrous solvents were stocked on activated molecular 
sieves 4Å under argon atmosphere, and degassed by argon bubbling prior to use. All 
reactions were carried out under argon atmosphere in oven-dried glassware with a 
magnetic stirring bar. 
1H NMR spectra were recorded on JEOL AL-400 (400 MHz) spectrometers. The 
chemical shifts were reported in parts per million (δ) relative to internal standard 
TMS (0 ppm) for CDCl3. The peak patterns are indicated as follows: s, singlet; d, 
doublet; dd, doublet of doublet; t, triplet; q, quartet; m, multiplet, brs, broad singlet. 
The coupling constants, J, are reported in Hertz (Hz). 13C NMR spectra were 
obtained by JEOL AL-400 (100 MHz) spectrometers and referenced to the internal 
solvent signals (central peak is 77.0 ppm in CDCl3). 31P NMR spectra were obtained 
by JEOL AL-400 (200 MHz) spectrometers and H3PO4 was used as an external 
standard (0.00 ppm). CDCl3 was used as a NMR solvent. High-resolution mass 
spectra (HRMS) were measured on ESI (Electrospray ionization) method at a JEOL 
GC-mate II. IR was measured in JASCO FT/IR-4100ST. Preparative thin-layer 
chromatography (PTLC) was performed with silica gel-precoated glass plates 
(Merck 60 GF254) prepared in our laboratory. Flash column chromatography was 
performed over silica gel 200-300.  
Experimental procedure for the preparation of amine 2 
In a two-neck flask purged with argon, a solution of 1,11-
dioxa[11]paracyclophane (1) (0.5 mmol) in Et2O (0.5 ml) was added followed by 
(+)-sparteine (1 equiv) and the resulting solution was cooled to -78 °C. sec-BuLi 
(0.98 M) (2 equiv) was added dropwise and stirred at -78 °C for 2 h. A solution of 
trimethylsilylmethyl azide (5 equiv) in Et2O (0.6 mL) was added dropwise and the 
reaction mixture was warmed to ambient temperature. The reaction was quenched 
with saturated aqueous solution of NH4Cl and extracted with EtOAc (10 ml × 3). 
The organic layer was washed with brine and dried with Na2SO4. The solution was 
evaporated and purified. 
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13-Amino-1,11-dioxa[11]paracyclophane (2): it was isolated by PTLC 
(hexane/ethyl acetate = 5/1). The title compound was obtained as yellow 
viscous oil (75.8 mg, 60%).  1H NMR (ppm) δ 6.90-6.88 (m, 1H), 6.45-
6.43 (m, 2H), 4.26-4.15 (m, 4H), 3.87 (brs, 2H), 1.71-1.61 (m, 4H), 
1.03-0.90 (m, 10H); 13C NMR (ppm) δ 155.7, 141.5, 140.0, 120.6, 110.0, 
108.2, 71.4, 71.3, 30.2, 30.0, 27.9, 26.1, 26.1, 25.7, 25.4; IR (cm -1) 3365, 
2924, 2851, 2362, 1617, 1506, 1457, 1198, 1163, 982; HRMS(ESI , 
positive): m/z  calcd. for C15H24NO2 [M+H]+: 250.1802; found: 250.1802. 
[α]2 3  D = +38.6 (c 0.57, CHCl3, 98% ee). Ee was determined by HPLC 
analysis using a chiral column (Daicel Chiralpak IA: 4 x 250mm, 254nm 
UV detector, rt, eluent: 40% EtOAc in hexane, flow rate: 0.5 mL/min, 
retention time: 10.2 min for minor isomer and 11.0 min for major 
isomer). 
General experimental procedure for reductive amination  
To a two-neck flask purged with argon, a solution of appropriate amine (0.1 mmol) 
and aldehyde (1.2 equiv) in 1,2-dichloroethane (0.3 mL) was added followed by 
NaBH(OAc)3 (3 equiv) and AcOH (0.02 mL). The reaction mixture was stirred till 
the completion of reaction. A saturated aqueous solution of K2CO3 was added to the 
reaction mixture and extracted with dichloromethane (10 ml × 3). The organic layer 
was washed with water, dried over Na2SO4 and evaporated to dryness. 
13-Benzylamino-1,11-dioxa[11]paracyclophane (3a): it was isolated 
by PTLC (hexane/ethyl acetate = 5/1). The title compound was obtained 
as yellow viscous oil (12.5 mg, 79%).1H NMR (ppm) δ 7.40-7.30 (m, 
4H), 7.25-7.23 (m, 1H), 6.84 (dd, J = 4.8, 3.8 Hz, 1H), 6.34-6.32 (m, 
1H), 6.28-6.27 (m, 1H), 4.77 (brs, 1H), 4.34-4.12 (m, 4H), 4.06-4.04 
(m, 2H), 1.61-1.47 (m, 4H), 0.95-0.74 (m, 10H); 13C NMR (ppm) δ 155.9, 
141.9, 141.1, 139.5, 128.5, 127.4, 127.1, 119 .4, 107.8, 104.3, 71.6, 71.4, 
47.9, 30.2, 30.1, 27.9, 26.2, 26.1, 25.8, 25.6 (two pair of peaks are 
overlapped at aromatic region); IR (cm -1) 2924, 2852, 2362, 2340, 1603, 
1516, 1456, 1182, 977, 697,419; HRMS(ESI , positive): m/z calcd. for 
C22H29NNaO2 [M+Na]+: 362.2090; found: 362.2091. [α]
2 5  
D = +63.2 (c  
0.76, CHCl3, 98% ee). Ee was determined by HPLC analysis using a 
chiral column (Daicel Chiralpak IA: 4 x 250mm, 254nm UV detector, 
rt, eluent: 10% EtOAc in hexane, flow rate: 1 mL/min, retention time: 
8.3 min for minor isomer and 10.7 min for major isomer).  
 
13-Methylamino-1,11-dioxa[11]paracyclophane (3b): it was isolated 
by PTLC (hexane/ethyl acetate = 5/1). The title compound was obtained 
as yellow viscous oil (11.7 mg, 45%). 1H NMR (ppm) δ 6.90-6.87 (m, 
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1H), 6.40-6.35 (m, 2H), 4.34 (brs, 1H), 4.26-4.15 (m, 4H), 2.88 (d, J = 
2.5 Hz, 3H), 1.69-1.61 (m, 4H), 1.04-0.90 (m, 10H); 13C NMR (ppm) δ 
156.1, 143.4, 141.3, 119.3, 107.3, 103.6, 71.6, 71.4, 30.5, 30.3, 30.0, 
28.0, 26.1, 26.1, 25.8, 25.4; IR (cm -1) 3426, 2923, 2852, 2362, 1606, 
1518, 1457, 1186, 981, 447, 419; HRMS(ESI , positive): m/z  calcd. for 
C16H26NO2 [M+H]+: 264.1958; found: 264.1958.  [α]
2 6  
D = +88.2 (c 1.32, 
CHCl3). 
 
13-Isopropylamino-1,11-dioxa[11]paracyclophane (3c): it was 
isolated by PTLC (hexane/ethyl acetate = 5/1). The title compound was 
obtained as pale yellow viscous oil (24.8 mg, 86%).  1H NMR (ppm) δ 
6.85-6.83 (m, 1H), 6.32-6.30 (m, 2H), 4.24-4.10 (m, 5H), 3.57 (brs, 1H), 
1.65-1.60 (m, 4H), 1.25-1.20 (m, 6H), 1.03-0.87 (m, 10H); 13C NMR 
(ppm) δ 156.0, 141.3, 141.0, 119.5, 106.8, 104.0, 71.6, 71.4, 43.6, 30.4, 
30.1, 27.9, 26.1, 26.1, 25.8, 25.4, 23.0, 22.9; IR (cm -1) 3419, 2924, 2853, 
2363, 1605, 1516, 1458, 1187, 420; HRMS(ESI , positive): m/z  calcd. 
for C18H30NO2 [M+H]+: 292.2270; found: 292.2271. [α]
2 5  
D =+98.4 (c 0.57, 
CHCl3). 
 
13-(Benzylamino)methyl-1,11-dioxa[11]paracyclophane (5a): it was 
isolated by PTLC (hexane/ethyl acetate = 3/1). The title compound was 
obtained as yellow viscous oil (21.5  mg, 64%). 1H NMR (ppm) δ 7.35-
7.30 (m, 4H), 7.26-7.24 (m, 1H), 7.02-7.00 (m, 1H), 6.99-6.94 (m, 2H), 
4.22-4.17 (m, 4H), 4.06 (d, J = 13.7 Hz, 1H), 3.83-3.74 (m, 2H), 3.63 
(d, J = 13.7 Hz, 1H), 2.02 (brs, 1H), 1.68-1.58 (m, 4H), 0.96-0.73 (m, 
10H); 13C NMR (ppm) δ 154.5, 152.6, 140.3, 133.0, 128.3, 128.1, 126.8, 
121.6, 120.0, 119.7, 71.7, 71.1, 52.9, 48.5, 30.0, 29.8, 27.7, 26.2, 26.0, 
25.8, 25.2 (two pairs of peaks are overlapped at aromatic region); IR 
(cm -1) 2925, 2854, 2361, 1491, 1456, 1199, 1150, 979, 824, 736, 698; 
HRMS(ESI, positive): m/z calcd. for C23H32NO2 [M+H]+: 354.2425; 
found: 354.2428. [α] 2 6  D = +13.0 (c 0.85, CHCl3, 97% ee). Ee was 
determined by HPLC analysis using a chiral column (Daicel Chiralcel 
OD-H: 4 x 250mm, 254nm UV detector, rt, eluent: 10% 2 -propanol in 
hexane, flow rate: 0.5 mL/min, retention time: 16.4 min for major 
isomer and 24.0 min for minor isomer).  
 
13-(Isopropylamino)methyl-1,11-dioxa[11]paracyclophane (5b): it 
was isolated by PTLC (hexane/ethyl acetate = 3/1). The title compound 
was obtained as yellow viscous oil (32.1 mg, 94%). 1H NMR (ppm) δ 
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6.97 (d, J = 2.4 Hz, 2H), 6.94-6.92 (m, 1H), 4.22-4.17 (m, 4H), 4.03 (d, 
J = 13.5 Hz, 1H), 3.61 (d, J = 13.5 Hz, 1H), 2.79-2.77 (dd, J = 5.9, 2.7 
Hz, 1H), 1.66-1.61 (m, 4H), 1.43 (brs, 1H), 1.07 (d, J = 5.6 Hz, 6H), 
0.97-0.67 (m, 10H); 13C NMR (ppm) δ 154.5, 152.6, 133.5, 121.5, 119.9, 
119.5, 71.7, 71.1, 47.4, 46.7, 30.1, 29.9, 27.8, 26.2, 26.0, 25.8, 25.3, 
23.0, 22.7. IR (cm -1) 3853, 3749, 3735, 3649, 2924, 2853, 2361, 1490, 
1457, 1193; HRMS(ESI, positive): m/z  calcd. for C19H32NO2 [M+H]+: 
306.2425; found: 306.2428. [α] 2 8  D = +8.8 (c 0.61, CHCl3). 
General procedure for the synthesis of phosphoramidite ligands (L1-L9)  
In a Schlenk tube evacuated and purged with argon (3 times), a solution of 
appropriate planar-chiral amine (3a-3c, 5a and 5b) (0.1 mmol) in THF (0.5 mL) and 
TMEDA (2 equiv) were added and cooled to -78 °C. A hexane solution of n-BuLi 
(1.54 M, 2 equiv) was added dropwise to the solution, and the reaction mixture was 
stirred for 2 h at -78 °C. A THF solution (0.6 mL) of commercially available 
chlorodioxaphosphepin (2 equiv) or in situ prepared 2,2′-biarylene 
phosphorochloridite [prepared by mixing the corresponding biaryl diol (0.20 mmol) 
and PCl3 (0.28 mmol) at 75 °C overnight] was added dropwise at -78 °C and warmed 
to room temperature overnight. The resulting solution was filtered through filter 
paper using dichloromethane and was evaporated to dryness. 
(Ra)-N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-
yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine ((Ra)-
L1): it was isolated by PTLC (hexane/ethyl acetate = 5/1). The title 
compound was obtained as foamy white solid (26.4 mg, 41%). Mp: 124 -
128 °C; 1H NMR (ppm) δ 8.04-7.90 (m, 4H), 7.68 (d, J = 8.8 Hz, 1H), 
7.57 (d, J = 8.7 Hz, 1H), 7.45-7.36 (m, 4H), 7.27-7.24 (m, 3H), 7.06-
7.04 (m, 4H), 6.97 (d, J = 8.7 Hz, 1H), 6.77 (d, J = 8.1 Hz, 1H), 6.53 
(s, 1H), 4.56-4.51 (m, 1H), 4.43-4.35 (m, 2H), 4.23 (dd, J = 14.4, 3.4 
Hz, 1H), 3.97-3.88 (m, 2H), 1.82-1.77 (m, 2H), 1.45-1.42 (m, 2H), 0.95-
0.80 (m, 8H), 0.72-0.71 (m, 2H); 13C NMR (ppm) δ 154.8, 150.0, 149.2, 
142.5, 139.6, 138.5, 137.9, 134.8, 132.8, 132.6, 131.5, 130.8, 130.3, 
129.1, 128.3, 127.9, 127.1, 127.0, 126.8, 126.1, 124.9, 124.7, 124.2, 
124.1, 122.6, 122.2, 122.1, 122.0, 121.6, 118.3, 71.4, 50.3, 30.1, 29.4, 
27.6, 26.5, 25.9, 25.8, 25.3  (a pair of peak at aliphatic region is 
overlapped.); 31P (ppm) δ 140.3.  IR (cm -1) 3749, 3735, 3649, 2921, 2361, 
2343, 1734, 1363, 1229, 420; HRMS(ESI , positive): m/z calcd. for 
C42H40NNaO4P [M+Na]+: 676.2584; found: 676.2587. [α]
2 3  
D = -193.7 (c  
0.91, CHCl3). 
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(Sa)-N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-
yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine ((Sa)-
L1): it was isolated by PTLC (hexane/ethyl acetate = 5/1). The title 
compound was obtained as foamy white solid (41.6 mg, 65%). Mp: 126 -
130 °C; 1H NMR (ppm) δ 7.98 (d, J = 8.5 Hz, 1H), 7.91 (d, J = 7.5 Hz, 
1H), 7.83 (d, J = 6.6 Hz, 1H), 7.75 (d, J = 8.6 Hz, 1H), 7.52 (d, J = 8.1 
Hz, 1H), 7.46-7.33 (m, 5H), 7.25-7.12 (m, 7H), 6.91 (brs, 2H), 6.79 (d, 
J = 6.9 Hz, 1H), 4.62 (d, J = 15.3 Hz, 1H), 4.39-4.21 (m, 3H), 4.13-4.03 
(m, 2H), 1.76-1.50 (m, 4H), 1.00-0.79 (m, 10H); 13C NMR (ppm) δ 155.1, 
149.8, 149.8, 149.7, 149.0, 138.3, 135.7, 135.5, 132.8, 132.6, 131.4, 
130.6, 130.4, 129.8, 128.4, 128.3, 128.2, 127.9, 127.1, 127.0, 126.6, 
126.1, 126.0, 124.9, 124.5, 122.0, 121.9, 121.0, 120.9, 118.1, 71.5, 70.8, 
49.8, 30.3, 29.6, 27.7, 26.6, 26.3, 25.1, 25.3; 31P (ppm) δ 140.7. IR (cm -
1) 2924, 2854, 2361, 1601, 1508, 1457, 1223, 966, 813, 445; HRMS(ESI , 
positive): m/z  calcd. for C42H40NNaO4P [M+Na]+: 676.2584; found: 
676.2587. [α] 2 3  D = -61.9 (c 0.51, CHCl3). 
 
(Ra)-N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-
ylmethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine 
((Ra)-L2): it was isolated by PTLC (hexane/ethyl acetate = 3/1). The 
title compound was obtained as foamy white solid (25.2 mg, 36%). Mp: 
113-117 °C; 1H NMR (ppm) δ 7.98 (d, J = 8.8 Hz, 1H), 7.91 (d, J = 8.1 
Hz, 1H), 7.82 (d, J = 8.1 Hz, 1H), 7.76 (d, J = 8.8 Hz, 1H), 7.61 (d, J = 
8.8 Hz, 1H), 7.39 (dd, J = 7.7, 7.7 Hz, 1H), 7.35-7.30 (m, 3H), 7.28 (d, 
J = 7.5 Hz, 2H), 7.25-7.18 (m, 5H), 7.15 (d, J = 8.7 Hz, 1H), 7.10-7.03 
(m, 2H), 6.92 (brs, 1H), 4.51 (dd, J = 15.3, 10.3 Hz, 1H), 4.20-4.08 (m, 
4H), 4.05 (dd, J = 15.3, 4.4 Hz, 1H), 3.69 (dd, J = 18.7, 15.4 Hz, 1H), 
3.38 (dd, J = 15.3, 5.9 Hz, 1H), 1.72-1.46 (m, 4H), 0.93-0.68 (m, 10H); 
13C NMR (ppm) δ 154.0, 153.3, 149.8, 149.5, 138.0, 132.8, 132.5, 131.4, 
130.7, 130.7, 130.1, 130.0, 128.4, 128.3, 128.2, 127.0, 127.0, 126.9, 
126.0, 125.9, 124.7, 124.5, 124.1, 124.1, 122.7, 122.4, 122.2, 121.9, 
120.3, 120.1, 72.0, 71.0, 47.3, 44.8, 30.0, 29.6, 27.8, 26.2, 26.1, 26.0, 
25.2; 31P (ppm) δ 147.0.  IR (cm -1) 2924, 2852, 2361, 2329, 1490, 1457, 
1230, 1200, 936, 822, 420; HRMS(ESI , positive): m/z  calcd. for 
C43H42NNaO4P [M+Na]+: 690.2739; found: 690.2744. [α]
2 6  
D = -113.0 (c  
1.06, CHCl3). 
 
 
 
 
63 
(Sa)-N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-
ylmethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine 
((Sa)-L2): it was isolated by PTLC (hexane/ethyl acetate = 3/1). The 
title compound was obtained as foamy white solid (32.8 mg, 45%). Mp: 
114-118 °C; 1H NMR (ppm) δ 7.98 (dd, J = 8.8, 3.1 Hz, 1H), 7.93 (dd, 
J = 8.3, 4.2 Hz, 1H), 7.84-7.81 (m, 2H), 7.56-7.53 (m, 1H), 7.44-7.31 
(m, 8H), 7.27-7.26 (m, 2H), 7.21-7.13 (m, 3H), 6.86-6.77 (m, 2H), 4.62-
4.55 (m, 1H), 4.35-4.28 (m, 1H), 4.20-4.12 (m, 1H), 3.83-3.67 (m, 4H), 
3.50-3.44 (m, 1H), 1.65-1.56 (m, 3H), 0.82-0.12 (m, 11H); 13C NMR 
(ppm) δ 155.0, 152.3, 149.8, 149.7, 149.2, 138.3, 132.8, 132.5, 131.3, 
130.8, 130.7, 130.2, 130.1, 128.9, 128.4, 128.2, 128.1, 127.5, 127.0, 
126.9, 126.1, 125.9, 124.8, 124.5, 122.5, 122.0, 121.6, 120.5, 119.6, 
119.2, 71.5, 71.3, 50.6, 42.5, 30.2, 29.3, 27.3, 25.4, 25.2, 24.5 (a pair 
of peak at aliphatic region is overlapped); 31P (ppm) δ 148.7. IR (cm -1) 
2929, 2362, 2343, 2328, 1507, 1489, 1230, 421; HRMS(ESI , positive): 
m/z  calcd. for C43H42NNaO4P [M+Na]+: 690.2740; found: 690.2744.  
[α]2 4  D = +174.5 (c 1.10, CHCl3). 
 
(Ra)-N-(1,11-Dioxa[11]paracyclophan-13-yl)-N-
methyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine 
((Ra)-L3): it was isolated by PTLC (toluene only). The title compound 
was obtained as foamy white solid (17.1 mg, 30%). Mp: 110 -115 °C; 1H 
NMR (ppm) δ 7.99 (dd, J = 8.8, 8.8 Hz, 2H), 7.94 (dd, J = 8.1, 3.3 Hz, 
2H), 7.59 (dd, J = 12.0, 8.8 Hz, 2H), 7.46-7.41 (m, 3H), 7.35 (d, J = 8.6 
Hz, 1H), 7.31-7.29 (m, 1H), 7.27 (s, 1H), 7.07 (d, J = 7.8 Hz, 1H), 6.90-
6.87 (m, 2H), 4.46-4.41 (m, 1H), 4.34-4.30 (m, 1H), 4.18-4.14 (m, 2H), 
2.73 (s, 3H), 1.78-1.77 (m, 1H), 1.71-1.65 (m, 2H), 1.05-0.84 (m, 11H); 
13C NMR (ppm) δ 155.7, 149.3, 149.1, 132.8, 132.6, 131.5, 130.7, 130.4, 
130.1, 128.3, 128.3,  127.0, 126.1, 124.9, 124.7, 124.2, 124.0, 124.0, 
122.7, 122.2, 119.1, 119.0, 117.8, 117.6, 71.6, 71.4, 34.9, 30.3, 29.6, 
27.7, 26.3, 26.1, 26.0, 25.3 ( two pairs of peaks in the aromatic region 
are overlapped); 31P (ppm) δ 144.0. IR (cm -1) 2924, 2362, 2328, 1746, 
1734, 1539, 1507, 1456, 1229, 420; HRMS(ESI , positive): m/z  calcd. 
for C36H36NNaO4P [M+Na]+: 600.2274; found: 600.2274. [α]
2 8  
D = -124.7 
(c 0.43, CHCl3). 
 
(Ra)-N-(1,11-Dioxa[11]paracyclophan-13-yl)-N-
isopropyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine 
((Ra)-L4): it was isolated by PTLC (hexane/ethyl acetate = 5/1). The 
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title compound was obtained as foamy white solid (12.4 mg, 20%). Mp: 
116-120 °C; 1H NMR (ppm) δ 8.0-7.89 (m, 4H), 7.67 (d, J = 8.7 Hz, 
1H), 7.56 (d, J = 8.7 Hz, 1H), 7.42-7.35 (m, 4H), 7.26-7.24 (m, 2H), 
7.05 (d, J = 8.8 Hz, 1H), 6.95 (d, J = 8.1 Hz, 1H), 6.65 (s, 1H), 4.50-
4.37 (m, 2H), 3.99 (d, J = 8.4 Hz, 1H), 3.78 (s, 1H), 3.58-3.53 (m, 1H), 
1.87-1.83 (m, 1H), 1.72-1.66 (m, 1H), 1.42-1.20 (m, 2H), 0.99-0.85 (m, 
8H), 0.96 (d, J = 6.3 Hz, 3H), 0.88 (d, J = 6.4 Hz, 3H), 0.80-0.66 (m, 
2H); 13C NMR (ppm) δ 179.8, 178.8, 154.1, 151.7, 150.1, 149.8, 132.9, 
132.7, 131.4, 130.8, 130.1, 129.8, 128.9, 128.4, 128.3, 127.7, 127.1, 
127.1, 126.0, 125.9, 124.7, 124.4, 122.6, 122.3, 120.4, 119.9, 71.7, 71.2, 
53.4, 30.2, 29.7, 29.6, 27.7, 26.6, 26.0, 25.6, 22.9, 21.5; 31P (ppm) δ 
144.4. IR (cm -1) 2926, 2360, 2339, 1735, 1540, 1509, 1490, 1363, 1231, 
948, 517, 458, 420; HRMS(ESI, positive): m/z  calcd. for C38H40NNaO4P 
[M+Na]+: 628.2584; found: 628.2587. [α] 3 0  D = -142.5 (c 0.87, CHCl3). 
 
N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-
yl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-amine (L5): it was isolated 
by PTLC (toluene only). The title compound was obtained as foamy 
white solid (38.9 mg, 41%). Mp: 68-74 °C; 1H NMR (ppm) δ 7.48-7.46 
(m, 2H), 7.36-7.26 (m, 6H), 7.11-7.05 (m, 5H), 6.97-6.93 (m, 1H), 6.78-
6.72 (m, 2H), 4.61-4.35 (m, 4H), 4.12-4.06 (m, 2H), 1.72-1.61 (m, 3H), 
0.92-0.78 (m, 11H); 13C NMR (ppm) δ 155.1, 151.9, 150.9, 149.9, 138.2, 
135.3, 135.1, 131.3, 130.6, 129.9, 129.8, 129.5, 129.3, 129.0, 128.0, 
126.8, 125.0, 124.6, 122.5, 122.2, 122.1, 121.5, 121.4, 118.1, 71.6, 71.3, 
49.8, 30.4, 29.6, 27.8, 26.5, 26.1, 25.9, 25.4; 31P (ppm) δ 141.0.  IR (cm -
1) 2924, 2852, 2361, 1493, 1474, 1457, 1436, 1246, 1192, 1166, 885; 
HRMS(ESI, positive): m/z  calcd. for C34H36O4NNaP [M+Na]+: 
576.2280; found: 576.2274. [α] 2 4  D = -90.5 (c 0.53, CHCl3). 
 
N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-
ylmethyl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-amine (L6): it was 
isolated by PTLC (hexane/ethyl acetate = 5/1). The title compound was 
obtained as foamy white solid (26.5 mg, 47%). Mp: 65 -70 °C; 1H NMR 
(ppm) δ 7.42 (d, J = 7.5 Hz, 1H), 7.39-7.36 (m, 5H), 7.34-7.24 (m, 4H), 
7.22-7.16 (m, 3H), 7.04 (d, J = 7.9 Hz, 1H), 6.91-6.90 (m, 2H), 4.41-
4.35 (m, 1H), 4.29-4.24 (m, 1H), 4.20-4.15 (m, 1H), 4.13-3.93 (m, 4H), 
3.89-3.86 (m, 1H), 1.71-1.54 (m, 3H), 1.16-1.09 (m, 1H), 0.88-0.75 (m, 
3H), 0.56-0.51 (m, 7H); 13C NMR (ppm) δ 154.8, 152.5, 151.9, 151.8, 
138.3, 131.4, 131.4, 130.4, 130.4, 129.7, 129.5, 129.3, 129.0, 128.6, 
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128.3, 127.2, 124.7, 124.2, 122.2, 121.7, 120.2, 120.1, 119.5, 71.8, 71.1, 
49.4, 43.3, 30.1, 29.7, 27.6, 25.8, 25.6, 25.6, 25.0 (a pair of peaks in 
the aromatic region is overlapped); 31P (ppm) δ 149.1.  IR (cm -1) 2927, 
2361, 2341, 1734, 1541, 1489, 1436, 1191, 884, 772, 447, 419; 
HRMS(ESI, positive): m/z  calcd. for C35H38NNaO4P [M+Na]+: 
590.2430; found: 590.2431. [α] 2 0  D = -8.7 (c 0.61, CHCl3). 
 
N-(1,11-Dioxa[11]paracyclophan-13-ylmethyl)-N-
isopropyldibenzo[d,f][1,3,2]dioxaphosphepin-6-amine (L7): it was 
isolated by PTLC (hexane/ethyl acetate = 5/1). The title compound was 
obtained as foamy white solid (15.4 mg, 30%). Mp: 130 -134 °C; 1H 
NMR (ppm) δ 7.42 (dd, J = 7.6, 1.6 Hz, 1H), 7.38 (dd, J = 7.6, 1.6 Hz, 
1H), 7.35 (dd, J = 7.7, 1.8 Hz, 1H), 7.31 (dd, J = 7.7, 1.6 Hz, 1H), 7.23-
7.17 (m, 5H), 6.80 (d, J = 1.6 Hz, 2H), 4.26-4.19 (m, 1H), 4.17-4.13 (m, 
2H), 4.04-3.97 (m, 2H), 3.85 (ddd, J = 12.0, 6.6, 3.1 Hz, 1H), 3.69-3.61 
(m, 1H), 1.65-1.58 (m, 1H), 1.56-1.48 (m, 1H), 1.43 (d, J = 6.7 Hz, 3H), 
1.27-1.23 (m, 1H), 1.14 (d, J = 6.7 Hz, 3H), 1.10-1.05 (m, 1H), 0.81-
0.74 (m, 2H), 0.52-0.39 (m, 8H); 13C NMR (ppm) δ 154.8, 152.6, 152.6, 
151.4, 133.5, 130.3, 130.3, 129.9, 129.5, 129.3, 128.9, 124.7, 124.0, 
122.4, 121.7, 120.2, 119.7, 118.9, 71.7, 71.2, 49.2, 41.3, 30.2, 29.7, 
27.5, 25.8, 25.6, 25.5, 25.0, 23.2, 23.0;  31P (ppm) δ 151.3.  IR (cm -1) 
2924, 2852, 2362, 1488, 1435, 1247, 1191, 1095, 1036, 888, 847, 765, 
419; HRMS(ESI, positive): m/z  calcd. for C31H38NNaO4P [M+Na]+: 
542.2432; found: 542.2431. [α] 2 8  D = +86.9 (c 0.84, CHCl3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-yl)-2,4,8,10-
tetramethyldibenzo[d,f][1,3,2]dioxaphosphepin-6-amine (L8): it was 
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isolated by PTLC (toluene only). The title compound was obtained as 
foamy white solid (33.2 mg, 55%). Mp: 82-86 °C; 1H NMR (ppm) δ 
7.14-7.11 (m, 3H), 7.09-7.05 (m, 6H), 6.96 (d, J = 8.6 Hz, 1H), 6.80-
6.77 (m, 2H), 4.67 (d, J = 14.4 Hz, 1H), 4.42 (dd, J = 14.4, 2.2 Hz, 1H), 
4.24 (dd, J = 5.1, 5.1 Hz, 2H), 4.20-4.07 (m, 2H), 2.47 (s, 3H), 2.46 (s, 
3H), 2.36 (s, 3H), 2.33 (s, 3H), 1.65-1.58 (m, 2H), 1.39-1.37 (m, 2H), 
0.96-0.83 (m, 4H), 0.80-0.67 (m, 6H); 13C NMR (ppm) δ 154.9, 149.3, 
149.2, 148.1, 148.0, 146.5, 137.8, 135.6, 135.4, 133.8, 132.8, 131.2, 
131.1, 129.8, 129.6, 128.1, 127.8, 126.8, 122.0, 120.1, 120.0, 117.3, 
71.4, 71.2, 48.5, 30.0, 29.1, 27.4, 26.3, 25.9, 25.6, 25.2, 20.9, 20.8, 17.0, 
16.7;  31P (ppm) δ 134.7.  IR (cm -1) 2923, 2852, 1600, 1494, 1478, 1457, 
1409, 1245, 1213, 1193, 1154, 1120, 1065, 857, 759, 699, 593, 476, 
418; HRMS(ESI, positive): m/z  calcd. for C38H44O4NNaP [M+Na]+: 
632.2897; found: 632.2900.  [α]2 7  D = -123.3 (c 0.56, CHCl3). 
 
N-Benzyl-N-(1,11-dioxa[11]paracyclophan-13-ylmethyl)-2,4,8,10-
tetramethyldibenzo[d,f][1,3,2]dioxaphosphepin-6-amine (L9): it was 
isolated by PTLC (hexane/ethyl acetate = 5/1). The title compound was 
obtained as white solid (24.5 mg, 39%). Mp: 76-80 °C; 1H NMR (ppm) 
δ 7.37 (d, J = 6.8 Hz, 2H), 7.31 (dd, J = 7.6, 7.6 Hz, 2H), 7.27-7.26 (m, 
1H), 7.14 (s, 1H), 7.01-6.98 (m, 3H), 6.92-6.90 (m, 3H), 4.24-4.20 (m, 
1H), 4.15-3.97 (m, 5H), 3.92 (d, J = 14.7, Hz, 2H), 2.36 (s, 3H), 2.32 
(s, 3H), 2.27 (s, 3H), 2.04 (s, 3H), 1.29-1.27 (m, 3H), 0.82-0.52 (m, 
11H); 13C NMR (ppm) δ 154.8, 152.7, 149.6, 147.9, 146.7, 138.1, 133.2, 
132.6, 131.3, 130.9, 130.9, 130.8, 130.0, 129.9, 129.2, 128.2, 127.8, 
127.7, 127.2, 120.3, 119.5, 99.9, 71.6, 71.4, 30.2, 29.7, 27.7, 25.9, 25.6, 
25.5, 25.2, 20.8, 20.8, 16.5, 16.5. (two pairs of peaks are overlapped at 
aliphatic region). 31P (ppm) δ 143.0. IR (cm -1) 2923, 2851, 2362, 2338, 
1735, 1489, 1363, 1214, 1194, 854, 420; HRMS(ESI , positive): m/z  
calcd. for C39H46NNaO4P [M+Na]+: 646.3054; found: 646.3057. [α]
2 5  
D = 
+24.1 (c 1.27, CHCl3). 
 
N-(2,5-dimethoxyphenyl)-N-methyldinaphtho[2,1-d:1',2'-
f][1,3,2]dioxaphosphepin-4-amine (L10): it was isolated by PTLC (toluene only). 
The title compound was obtained as foamy white solid (13.9 mg, 29%). Mp: 89-
92 °C; 1H NMR (ppm) δ 7.97-7.89 (m, 4H), 7.56-7.53 (m, 2H), 7.45-7.33 (m, 4H), 
7.28-7.22 (m, 2H), 6.88-6.84 (m, 2H), 6.72-6.69 (m, 1H), 3.89-3.87 (m, 3H), 3.75-
3.73 (m, 3H), 2.59-2.57 (m, 3H); 13C NMR (ppm) δ 153.9, 150.2, 150.1, 149.5, 135.2, 
135.0, 132.9, 131.4, 130.8, 130.2, 129.9, 128.3, 128.2, 127.0, 126.9, 126.0, 124.0, 
 
 
67 
124.0, 122.7, 122.2, 122.0,  115.0, 114.9, 113.4, 111.1, 99.9, 56.6, 55.7, 35.0; 31P 
(ppm) δ 144.7. IR (cm-1) 2927, 1614, 1587, 1500, 1460, 1327, 1269, 1221, 1063, 
937, 820; HRMS(ESI, positive): m/z calcd. for C29H25NO4P [M+H]+: 482.1517; 
found: 482.1516. [α]32. D = -72.1 (c 0.77, CHCl3). 
 
Experimental procedure for enantioselective alkylation in Table 2 
In a schlenk tube, [Pd(allyl)Cl]2 catalyst (2.0 mol%) and the ligand (8.0 mol%) was 
dissolved in DCM (0.9 ml) and stirred for 40 min at the desired temperature. (E)-
1,3-Diphenylallyl acetate (6) (0.03ml, 0.15mmol) was added and stirred for another 
15 min. Dimethyl malonate (7) (0.03ml, 1.8 equiv) was added followed by addition 
of BSA (1.3 equiv) and KOAc (1.3 equiv), then stirred at the desired temperature for 
24-48 h. The reaction mixture was diluted by DCM, filtered and evaporated. The 
crude mixture was purified by PTLC. The absolute configuration of product 8 was 
determined by the comparison of the sign of optical rotation with that in the 
literature.13  
Experimental procedure for conjugate addition in Table 3 
In a schlenk tube, Cu catalyst (2.8 mol%) and the ligand (6 mol%) were dissolved 
in toluene (0.8 ml) and stirred for 1 h at 0 °C. (E)-Chalcone (9) (20.8 mg, 0.1 mmol) 
was added followed by dropwise addition of diethylzinc (3 equiv) at 0 °C. The 
reaction mixture was stirred at 0 °C for 1-6 h, then quenched with saturated NH4Cl 
solution. The solution was extracted with Et2O (×3 times) and washed with saturated 
brine solution. The reaction mixture was dried over Na2SO4 and evaporated. Crude 
product was purified by PTLC. The absolute configuration of product 10 was 
determined by the comparison of the sign of optical rotation with that in the 
literature.14 
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Introduction of Indolo[1,2-a]indole Derivatives 
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• Background 
 Diverse biological and pharmacological properties were exhibited by nitrogen-
containing heterocycles. Particularly, the foundation for many well-known 
medicinally active compounds1 is an indole core. For medicinal chemists,2 
convenient methods for constructing indole-fused skeletons are extremely valuable. 
Significant attention was devoted to studying diverse synthetic analogues of indole. 
To synthesize new drugs, new methodologies for synthesizing indole derivatives are 
essential.3 Among these compounds, there is particular interest in  indoloindoles, in 
which indole fragments are fused to have in common carbon atoms of the pyrrole 
ring (for example, 5H,10H-indolo[3,2-b]indole (1)), carbon and nitrogen atoms of 
the pyrrole rings (for example, 10H-indolo[1,2-a]indole (2)), or carbon atoms of the 
benzene ring (for example, 1H,6H-indolo[7,6-g]indole (3) and 3H, 8H,-indolo[4,5-
e]indole (4))4 (Fig. 1).  
 
 
 
 
Fig 1: Various types of indoloindoles 
 
Indoloindoles are particularly known as chromogenic and fluorogenic indicators. 
They are also well-known as materials for organic electroluminescent devices5 and 
for electronic devices,6 such as organic integrated circuits, organic field-effect 
transistors, organic solar cells, and organic light-emitting diode (Fig. 2). 
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Fig 2. Compounds used in electroluminescence and electronic devices 
 
The first non-catalytic approach to synthesizing indoloindolone was described by 
Larock’s group. The novel indoloindolone ring system was obtained by reacting 
methyl indole-2-carboxylates and arynes.7 It tolerates appreciable functionality and 
has broader substrate scope. It afforded a high yield and the reaction proceeded under 
mild conditions (Scheme 1). 
 
 
 
 
 
 
 
 
Scheme 1: [3+2] annulation reaction 
 
 
  
Dominguez reported a new synthetic route to develop indolo[1,2-a]indole 
derivatives. The key step in this strategy was Caryl-N bond formation. This 
represented the first Cu-catalyzed intramolecular C-H arylation of indole via C-H 
functionalization (Scheme 2).8 
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Scheme 2: Preparation of indolo[1,2-a]indole 
 
Ramana developed a tetracyclic indoloindolone core from 2,2’-bis-
bromochalcones by using Cu catalyst. This reaction formed three C-N bonds in one 
pot; namely, Cu-catalyzed SNAr with azide, C-H bond insertion by nitrene, and an 
intramolecular Ullmann reaction (Scheme 3).9 
 
 
 
 
 
 
 
Scheme 3: Synthesis of indoloindolone 
 
 Cu-mediated selective dual C-H bond cleavage was reported by Ji. This novel 
approach provided highly functionalized pyrroloindole derivatives. Both a 
quaternary center and a five-membered ring were formed in this reaction (Scheme 
4).10 
 
 
 
 
 
 
 
 
 
Scheme 4: Cu-mediated indoloindole synthesis 
 
 
74 
An intramolecular Friedel-Crafts acylation was presented for synthesizing an 
indoloindolone scaffold using HFIP (Scheme 5).11   
 
 
 
 
 
 
 
 
Scheme 5: Protocol for indoloindolone synthesis 
 
 
 An effective synthetic strategy was developed for synthesizing fused indoles of 
[1,2-a]indol-10-imines through a Cu(OTf)2-catalyzed intramolecular cyclization by 
reacting N-(2-cyanophenyl)indoles in the presence of diaryliodonium triflate salts 
under mild conditions (Scheme 6).12  
 
 
 
 
 
 
 
 
 
Scheme 6: Cu-catalyzed annulation 
 
A method for a highly selective indoloindolone scaffold through a Ag-catalyzed 
C-H bond functionalization was reported. This involves direct oxidative coupling 
between aldehyde C-H and aromatic C-H bonds. A direct annulation of N-(2-
formylaryl)indoles was developed for synthesizing a medicinally important indole-
fused indolone moiety (Scheme 7).13 
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Scheme 7: Synthesis of indoloindolone 
 
 A strategy for synthesizing indolo[1,2-a]indoles14 was reported by Roy 
involving sequential Pd-catalyzed indole-N-arylated aldoxime annulation (Scheme 
8). 
 
 
 
 
 
 
 
Scheme 8: Pd-catalyzed synthesis of indolo[1,2-a]indoles 
 
        A novel protocol for Pd-catalyzed indole C-H activation, carbopalladation to 
alkyne moiety, and arylation with diaryliodonium salts was reported by Greaney.15 
Functionalized indole alkenes were synthesized in excellent yield with Z-alkene 
selectivity (Scheme 9).  
 
 
 
 
 
 
 
 
Scheme 9: Synthesis of tetrasubstituted olefin moiety 
 
An efficient strategy was developed for synthesizing indole-fused indolone via  
Pd-catalyzed cyclocarbonylation of cyclic diaryliodoniums prepared from iodoarene 
and mCPBA (Scheme 10).16 
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Scheme 10: Synthesis of indole-fused indolone 
 
 Wang reported Pd-catalyzed formal [4+1] annulation. This involved formation of 
two carbon-carbon bonds at a carbenic center. The key steps were migratory 
insertion of a metal carbene and C(sp2)-H bond functionalization (Scheme 11).17  
 
 
 
 
 
 
 
 
Scheme 11: Pd-catalyzed synthesis of indolo[1,2-a]indole 
 
 Perumal described a highly regio- and stereocontrolled strategy for the 
preparation of tetrasubstituted olefins via a Pd-catalyzed process.18 This involves 
double carbopalladation and C-H bond activation (Scheme 12). 
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Scheme 12: Synthesis of tetrasubstituted alkene 
 
An efficient strategy was described for synthesizing indole-fused indoles using 
aryne and base under transition-metal-free conditions (Scheme 13).19 
 
 
 
 
 
 
 
 
Scheme 13: Synthesis of indoloindoline derivatives 
 
An eight-membered ring synthesis for fused indolo-quinoline was described by 
Shi. A Au-catalyzed cycloisomerization involves two-fold hydroarylation with 
indole (Scheme 14).20 
 
 
 
 
 
 
 
 
Scheme 14: Synthesis of Au-catalyzed indoloquinoline 
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• Purpose of The Research in This Chapter 
 
As mentioned above, indoloindoles are attractive scaffolds for potential biological 
activity. They are also used as indicators and in electroluminescence and electronic 
devices, such as organic solar cells and organic field effect transistors. 
 
The author described various methods for synthesizing indoloindoles. Most of the 
strategies involved Pd- or Cu-catalyzed processes. Only one method used Au-
catalyzed cycloisomerization for the preparation of an eight-membered-fused 
indolo-quinoline as an endo product. 
 
Against this background, chapter 5 discusses the synthesis of indoloindoles 
through Au-catalyzed cycloisomerization. This provided a 5-exo-dig 
cycloisomerized product. Photophysical properties were also discussed including 
UV-VIS, fluorescence spectroscopy, and fluorescence quantum yield.  
 
 
 
 
 
 
Scheme 15: Outline of Au-catalyzed cycloisomerization 
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Chapter 5 
Synthesis of Indolo[1,2-a]indole Derivatives and Their 
Photophysical Properties 
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• Background 
Cycloisomerization is an atom economical process and an efficient protocol for 
the preparation of cyclic compounds.1 Among various transformations, 
cycloisomerization initiated by activation of the alkyne moiety using transition metal 
catalyst, especially gold catalyst, is most well-known. 
Shibata’s group recently reported Au(I)-catalyzed reaction for the construction of 
medium ring system.2 During the investigation of substrate scope, the reaction of N-
(2-(arylethynyl)phenyl)indole proceeded at the undesired C2 position instead of C7 
position  of the indole ring, which afforded nitrogen-containing tetracyclic 
compound as 5-exo-dig product (Scheme 1).2a 
 
   
 
 
 
 
 
Scheme 1: Preliminary result of an indole substrate 
 
Purpose of This Chapter 
 
       As mentioned above, N-(2-(arylethynyl)phenyl)indole realized 5-exo-dig-
selective cycloisomerization and indoloindole skeleton was constructed, which is an 
important class of scaffold as described in Chapter 4. 
 
   The author focused on the synthesis of indolo-indoles through Au-catalyzed 
cycloisomerization. Various substituents were available including electron-donating 
and electron-deficient groups. Substituents were also varied on the indole ring. 
Photophysical properties, such as UV-VIS absorption and fluorescence spectra, and 
fluorescence quantum yield, were measured. 
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Scheme 2: Outline synthesis of indoloindoles 
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• Results and Discussion    
 
The author screened the reaction conditions for the intramolecular cyclo-
isomerization of N-(2-(p-tolylethynyl)phenyl)indole (1a) in DCE (Table 1). A 
cationic Au(I) catalyst prepared by the combination of AuCl(PPh3) and silver salts 
was used and AgOTf afforded of 5-exo-dig product 2a in moderate yield without 
forming 6-endo-dig product 3a3 (Entries 1-3). The cationic Pt(II) and Pd(II)  afforded 
2a,  in lower yields (Entries 4 and 5). AgOTf  and  trifluoromethanesulfonic acid 
could also promote the cycloisomerization, but the reaction gave many inseparable 
products, and the isolated yields were low (Entries 6 and 7). When electron-deficient 
phosphine ligands with cationic Au(I) catalyst were used, the reaction progressed 
even at room temperature, but alkyne 1a was not completely consumed and the yield 
of 2a was lower at higher reaction temperature than Entry 3 (Entries 8 and 9). Hence, 
the author decided Entry 3 as the best conditions.  
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Table 1: Screening of reaction conditions 
 
 
  
 
 
 
 
Entry Catalyst Additive Temp. and Time Yield of 2a (%) 
1 AuCl(PPh3) AgOTf  rt, 24 h 21 
2 AuCl(PPh3)  AgOTf  60 °C, 24 h 33 
3 AuCl(PPh3) AgOTf 80 °C, 24 h 58 
4a PtCl2(PPh3)2 AgOTf r.t., 1 h, then 60 °C, 24 h 45 
5a PdCl2(PPh3)2  AgOTf  60 °C, 24 h 18 
6 AgOTf  none 80 °C, 3 h 22 
7b TfOH  none r.t., 1 h, then 60 °C, 1 h 19 
8 AuCl[P(4-F3CC6H4)]  AgOTf  r.t., 5 h, then 80 °C, 24 h 56 
9 AuCl[P(C6F5)3] AgOTf  r.t., 1 h, then 80 °C, 2 h 29 
    a AgOTf (20 mol %) was used. b TfOH (30 mol%) was used. 
 
Substrate Scope 
 
The author examined the reaction of N-(2-(arylethynyl)phenyl)indoles 1b-1e, 
which possessed different substituents at the position para- to the arene moiety, 
under the ideal reaction conditions (Table 2, Entries 1-4). Compared with the phenyl 
group, the electron-rich p-anisyl group afforded the highest yield of 76% (Entries 1 
and 2). While electron-deficient aryl group could also be available, the yield was 
lower (Entries 3 and 4). The starting material was not consumed completely and the 
 
 
86 
reaction was slow in case of electron-deficient group. Concerning the substituents 
on the indole ring, the author conducted the cycloisomerization of 5- and 6-
substituted indoles and get the tetracyclic products (Entries 5-7). For each and 
everyone entry, 5-exo-dig cycloadducts were obtained as a Z-isomer and no 6-endo-
dig cycloadducts were found. 
 
Table 2: Substrate scope 
 
 
 
 
 
 
 
 
 
Entry R Ar Time 
(h) 
Yield (%) 
1 H Ph (1b) 24 71 (2b) 
2 H 4-MeOC6H4 (1c) 6 76 (2c) 
3 H 4-FC6H4 (1d) 6 55 (2d) 
4 H 4-CF3C6H4 (1e) 24 50 (2e) 
5 5-MeO 4-MeOC6H4 (1f) 6 67 (2f) 
6 6-Me  4-MeOC6H4 (1g) 6 61 (2g) 
7 6-F 4-MeOC6H4 (1h) 6 60 (2h) 
 
 
 
 
 
 
 
 
87 
Endo Selectivity 
 
While alkynes with aryl group afforded 5-exo-dig cycloadducts, an alkyne with 
alkyl group gave 6-endo-dig cycloadduct selectively (Scheme 3). The reason for the 
endo selectivity is that electron-donating alkyl group increases electron density at 
the distal position. As a result, nucleophilic addition by indole moiety proceeds at 
the other end of the alkyne moiety to give endo product.3 
 
 
 
 
 
 
 
 
Scheme 3: Endo-selective product 
 
Reason for the Z-selectivity in the products 
 
In general, trans-alkenyl gold complexes as intermediates were formed from the 
nucleophilic Markovnikov attack to activated alkynes. This type of activation mode 
is often observed in Au-catalyzed cycloisomerization.4 
 
 
 
 
 
 
 
Scheme 4: Mechanism for Z-selectivity 
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Photophysical Properties 
 
The author evaluated the photophysical properties of the obtained compounds 
by UV-VIS absorption and fluorescence spectroscopies (Table 3). These compounds 
emitted fluorescence in the visible range of 400-600 nm.  There was not much effects 
by para-substituent on aryl group. An electron-withdrawing trifluoromethylphenyl 
group (2e: max(em) = 511 nm) showed a red shift compared to the phenyl group (2b: 
max(em) = 492 nm), whereas 4-tolyl (2a: max(em) = 487 nm) and 4-anisyl group (2c: 
max(em) = 484 nm) induced a blue-shift (Entries 1-3 and 5). The 5-position on the 
indoloindole skeleton was more sensitized from the 6 position when compared with 
fluorescence maxima of 2c and 2f-2h (Entries 3, 6-8).  Electron-donating methyl 
group exhibited fluorescence at 487 nm, but electron-withdrawing fluoro group 
exhibited fluorescence at 478 nm (Entries 7 and 8). For the absorption spectra the 
effect of substituents were less for example, the maximum absorption wavelength 
 (max(abs)) of 2 were found around 395-404 nm. Electron-withdrawing group on the 
scaffold showed lower absorbance than electron-donating group (Entries 6-8). Most 
of these compounds exhibited emissions below 500 nm except 2e. The reason might 
be due to insufficient conjugation of the aryl group with indoloindole scaffold. The 
effect of substituents on both of aryl and indole rings were little in the fluorescence 
quantum yield. The 6-endo-dig product gave lower fluorescence quantum yield than 
the aryl substituted 5-exo-dig product.  
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Table 3: Photophysical properties 
 
 
 
 
 
 
 
 
 
 
 
 
(a)Measured in CH2Cl2. (b) 2a 1.9х10-6 M; 2b 1.7х10-6 M; 2c 3.0х10-6 M; 2d 1.5х10-6 M; 2e  
1.6х10-6 M; 2f  1.9х10-6 M; 2g 2.4х10-6 M; 2h 3.3х10-6 M; 3i 1.2х10-6 M. (c) Excitation  
wavelength: 2a: 280 nm; 2b: 280 nm; 2c: 282 nm, 2d: 280 nm; 2e: 282 nm; 2f: 283 nm; 
 2g: 281 nm; 2h: 277 nm; 3i 278 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Entry Comp. λmax(abs) (nm) [ɛ (х103 cm-1)][a,b] λmax(em) (nm)[a,b,c] Φ[a,b,c] 
1 2a 255 (1.2), 280 (1.6), 401 (0.3) 487 0.67 
2 2b 280 (2.5), 399 (0.3) 492 0.23 
3 2c 238 (1.4), 282 (1.9), 398 (0.3) 484 0.64 
4 2d 245 (1.8), 280 (2.2), 400 (0.4), 491 0.60 
5 2e 242 (2.1), 282 (2.0), 395 (0.4) 511 0.42 
6 2f 234 (2.6), 283 (3.8), 401 (0.7) 487 0.49 
7 2g 253 (2.6), 281 (4.1), 404 (0.8) 491 0.66 
8 2h 251 (1.6), 277 (2.3), 397 (0.5) 478 0.67 
9 3i 256 (2.6), 283 (4.1), 401 (0.8) 452 0.30 
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UV-VIS spectra 
 
 
 
 
Fluorescence Spectra 
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• Conclusion 
 
The author has developed a simple protocol for the synthesis of indoloindole 
derivatives by Au-catalyzed cycloisomerization. While aryl-substituted alkynes 
afforded 5-exo-dig products, an alkyl-substituted alkyne provided 6-endo-dig 
product. The author has also measured photophysical properties, such as UV-VIS 
absorption and fluorescence spectrocopies, and fluorescence quantum yield. On the 
UV-VIS spectra the effect of substituents were little. Fluorescence was observed at 
the visible region of 400-600 nm. Moderate quantum yield was generally achieved. 
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• Experimental Section  
 
General 
Unless otherwise noted, all materials were purchased from commercial suppliers 
and used as received. Anhydrous solvents were stocked on activated molecular 
sieves 4Å under argon atmosphere, and degassed by argon bubbling prior to use. All 
reactions were carried out under argon atmosphere in oven-dried glassware with a 
magnetic stirring bar. 
1H NMR spectra were recorded on JEOL AL-400 (400 MHz) spectrometers. The 
chemical shifts were reported in parts per million (δ) relative to internal standard 
TMS (0 ppm) for CDCl3. The peak patterns are indicated as follows: s, singlet; d, 
doublet; dd, doublet of doublet; t, triplet; q, quartet; m, multiplet, brs, broad singlet. 
The coupling constants, J, are reported in Hertz (Hz). 13C NMR spectra were 
obtained by JEOL AL-400 (100 MHz) spectrometers and referenced to the internal 
solvent signals (central peak is 77.0 ppm in CDCl3). 19F NMR spectra were obtained 
by JEOL ECX-500 (470 MHz) spectrometers and referenced to the fluorine 
resonance of external standard: trifluoroacetic acid (-76.5 ppm). High-resolution 
mass spectra (HRMS) were measured on ESI (Electrospray ionization) method at a 
JEOL GC-mate II. UV-vis spectra were measured on a JASCO V-630 photometer. 
Fluorescence spectra were taken on a JASCO FP-8200 spectrofluorometer and 
quantum yields were determined with an integrating sphere (diameter 10 cm). 
Absolute PL quantum yield was measured by Hamamatsu Photonics C9920-02 
spectrometer. Preparative thin-layer chromatography (PTLC) was performed with 
silica gel-precoated glass plates (Merck 60 GF254) prepared in our laboratory. Flash 
column chromatography was performed over silica gel 200-300. Gold complexes 
and silver salts were weighed and handled under an argon atmosphere in globe box 
at room temperature. 
  
General procedures for the cycloisomerization in Table 2 : AuCl(PPh3) (0.0050 
mmol), AgOTf (0.0050 mmol), and N-(2-alkynylphenyl)indoline derivatives 1 
(0.050 mmol) were placed in a Schlenk tube under an argon atmosphere in globe 
box, which was then evacuated and backfilled with argon (×3). To the reaction vessel 
was added anhydrous DCE (0.50 mL), then the solution was stirred at 80 °C (bath 
temperature). The reaction mixture was cooled to room temperature, and the solution 
was passed through cotton filtration. After removal of solvent, the crude products 
were purified by PTLC to give 2a-h. 
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1-(2-(Phenylethynyl)phenyl)-1H-indole (1b): it was isolated by PTLC (hexane 
only). The title compound was obtained as yellow viscous oil (78.1 mg, 85%). 1H 
NMR δ 7.71 (dd, J = 7.3, 1.8 Hz, 2H), 7.53-7.47 (m, 3H), 7.42-7.36 (m, 2H), 7.26-
7.15 (m, 5H), 7.08 (dd, J = 7.6, 1.8, Hz, 2H), 6.71 (d, J = 3.2 Hz, 1H); 13C NMR δ 
140.9, 136.7, 133.5, 131.6, 129.3, 129.0, 128.6, 128.3, 127.3, 127.2, 122.9, 122.2, 
121.0, 120.3, 111.2, 103.0, 94.7, 86.4 (two pairs of peaks at the aromatic region are 
overlapped); HRMS (ESI, positive): m/z calcd. for C22H16N ([M+H]+) 294.1277, 
found 294.1277.  
1-(2-((4-Methoxyphenyl)ethynyl)phenyl)-1H-indole (1c): it was isolated by 
PTLC (hexane/ethyl acetate = 99/1). The title compound was obtained as brown 
viscous oil (93.2 mg, 92%). 1H NMR δ 7.72-7.67 (m, 2H), 7.51-7.36 (m, 5H), 7.22-
7.15 (m, 2H), 7.02 (d, J = 8.7 Hz, 2H), 6.75-6.67 (m, 3H), 3.67 (s, 3H); 13C NMR δ 
159.9, 140.7, 136.7, 133.2, 133.0, 129.3, 128.8, 127.3, 127.1, 122.1, 121.4, 120.9, 
120.3, 114.9, 114.0, 111.3, 102.9, 94.9, 85.2, 55.4 (a pair of peaks at the aromatic 
region is overlapped); HRMS (ESI, positive): m/z calcd. for C23H18NO ([M+H]+) 
324.1383, found 324.1383.  
1-(2-((4-Fluorophenyl)ethynyl)phenyl)-1H-indole (1d): it was isolated by PTLC 
(hexane/ethyl acetate = 99/1). The title compound was obtained as brown viscous 
oil (82.9 mg, 85%). 1H NMR δ 7.69 (d, J = 8.7 Hz, 2H), 7.50-7.34 (m, 5H), 7.19-
7.17 (m, 2H), 7.01-7.00 (m, 2H), 6.91-6.87 (m, 2H), 6.70-6.68 (m, 1H); 13C NMR δ 
163.9 (d, J = 249.4 Hz), 140.9, 136.7, 133.5, 133.3, 133.2, 129.2, 128.9 (d, J = 12.9 
Hz), 127.4 (d, J = 16.8 Hz), 122.2, 121.0, 120.9, 120.2, 118.9, 118.8, 115.7 (d, J = 
22.0 Hz), 111.2, 103.0, 93.7, 86.1; 19F NMR δ -110.4.  HRMS (ESI, positive): m/z 
calcd. for C22H15FN ([M+H]+) 312.1183, found 312.1183.  
1-(2-((4-(Trifluoromethyl)phenyl)ethynyl)phenyl)-1H-indole (1e): it was 
isolated by PTLC (hexane/ethyl acetate = 99/1). The title compound was obtained 
as brown viscous oil (78.1 mg, 69%). 1H NMR δ 7.71 (d, J = 7.8 Hz, 2H), 7.58-7.44 
(m, 6H), 7.35 (d, J = 8.2 Hz, 1H), 7.20-7.16 (m, 2H), 7.11 (d, J = 7.8 Hz, 2H), 6.72 
(d, J = 2.6 Hz, 1H); 13C NMR δ 141.3, 136.6, 133.5, 131.6, 129.9, 129.0, 128.9, 
127.4, 127.2, 125.3 (q, J = 4.1 Hz), 125.0, 122.2, 121.0, 120.3, 111.2, 103.1, 93.1, 
88.6 (three pairs of peaks at the aromatic region are overlapped); 19F NMR δ -62.8; 
HRMS (ESI, positive): m/z calcd. for C23H15F3N ([M+H]+) 362.1150, found 
362.1151.  
5-Methoxy-1-(2-((4-methoxyphenyl)ethynyl)phenyl)-1H-indole (1f): it was 
isolated by PTLC (hexane/ethyl acetate = 95/5). The title compound was obtained 
 
 
94 
as yellow viscous oil (66.8 mg, 66%). 1H NMR δ 7.68 (d, J = 7.3 Hz, 1H), 7.58-7.41 
(m, 3H), 7.38-7.34 (m, 1H), 7.28 (d, J = 9.2 Hz, 1H), 7.18 (s, 1H), 7.08 (d, J = 2.3 
Hz, 2H), 6.87 (dd, J = 8.7, 2.3 Hz, 1H), 6.76 (d, J = 8.7 Hz, 2H), 6.63-6.61 (m, 1H), 
3.89 (s, 3H), 3.71 (s, 3H); 13C NMR δ 159.9, 154.6, 140.7, 133.3, 133.1, 131.9, 129.9, 
129.5, 128.8, 127.1, 126.9, 121.1, 115.0, 114.0, 112.2, 112.0, 102.8, 102.6, 94.7, 
85.2, 56.1, 55.4 ; HRMS (ESI, positive): m/z calcd. for C24H19NNaO2 ([M+Na]+) 
376.1308, found 376.1308.  
1-(2-((4-Methoxyphenyl)ethynyl)phenyl)-6-methyl-1H-indole (1g): it was 
isolated by PTLC (hexane/ethyl acetate = 99/1). The title compound was obtained 
as brown viscous oil (71.3 mg, 70%). 1H NMR δ 7.69 (d, J = 7.3 Hz, 1H), 7.60 (d, J 
= 7.8 Hz, 1H), 7.52-7.37 (m, 4H), 7.18-7.16 (m, 1H), 7.07-7.01 (m, 3H), 6.75 (d, J 
= 8.7 Hz, 2H), 6.66-6.64 (m, 1H), 3.77 (s, 3H), 2.43 (s, 3H); 13C NMR δ 159.9, 140.7, 
137.0, 133.3, 133.0, 131.9, 128.8, 127.2, 127.1, 126.8, 122.0, 121.3, 120.6, 115.1, 
113.9, 111.2, 102.7, 94.8, 85.2, 55.4, 21.9 (a pair of peaks at the aromatic region is 
overlapped); HRMS (ESI, positive): m/z calcd. for C24H19NNaO ([M+Na]+) 
360.1358, found 360.1359.  
6-Fluoro-1-(2-((4-methoxyphenyl)ethynyl)phenyl)-1H-indole (1h): it was 
isolated by PTLC (hexane/ethylacetate = 95/5). The title compound was obtained as 
yellow viscous oil (81.0 mg, 80%). 1H NMR δ 7.68 (d, J = 7.8 Hz, 1H), 7.62-7.58 
(m, 1H), 7.46-7.40 (m, 4H), 7.01 (d, J = 9.2 Hz, 3H), 6.95-6.90 (m, 1H), 6.74 (d, J 
= 8.7 Hz, 2H), 6.67 (d, J = 2.8 Hz, 1H), 3.77 (s, 3H); 13C NMR δ 161.3 (d, J = 237.5 
Hz), 159.9, 140.2, 136.8 (d, J = 12.2 Hz), 133.3, 133.0, 128.9 (d, J = 3.8 Hz), 127.7, 
126.9, 125.3, 121.6 (d, J = 10.0 Hz), 121.4, 114.8, 114.0, 109.1 (d, J = 24.4 Hz), 
108.8, 102.9, 97.9 (d, J = 26.8 Hz), 95.1, 84.8, 55.3; 19F NMR δ -120.8; HRMS (ESI, 
positive): m/z calcd. for C23H17FNO ([M+H]+) 342.1285, found 342.1289.  
1-(2-(Hept-1-yn-1-yl)phenyl)-1H-indole (1i): it was isolated by PTLC 
(hexane/dichloromethane = 8/2). The title compound was obtained as a colourless 
viscous oil (93.7 mg, 44%); 1H NMR δ 7.70 (d, J = 7.3 Hz, 1H), 7.60 (d, J = 7.8 Hz, 
1H), 7.45-7.32 (m, 5H), 7.22-7.15 (m, 2H), 6.67 (d, J = 1.4 Hz, 1H), 2.18 (t, J = 6.9 
Hz, 2H), 1.32-1.12 (m, 6H), 0.84 (t, J = 6.9 Hz, 3H); 13C NMR δ 140.5, 136.3, 133.4, 
128.9, 128.6, 128.1, 127.2, 126.9, 121.6, 121.5, 120.6, 119.8, 110.9, 102.5, 95.9, 
77.3, 30.9, 26.7, 22.0, 19.4, 13.6; HRMS (ESI, positive): m/z calcd. for C21H22N 
([M+H]+) 288.1747, found 288.1747.  
(Z)-10-Benzylidene-10H-indolo[1,2-a]indole (2b): it was isolated by PTLC 
(hexane/dichloromethane = 9/1). The title compound was obtained as a yellow solid 
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(20.8 mg, 71%); mp 100-102 °C; 1H NMR δ 8.62 (d, J = 8.2 Hz, 1H), 8.52 (d, J = 
8.7 Hz, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.75-7.71 (m, 2H), 7.69-7.67 (m, 1H), 7.64-
7.60 (m, 1H), 7.55-7.30 (m, 6H),  7.12 (s, 1H), 6.87 (s, 1H); 13C NMR δ 138.9, 136.7, 
136.3, 133.6, 133.1, 129.1, 128.8, 128.6, 128.5, 128.4, 124.8, 123.1, 123.0, 122.1, 
122.0, 121.5, 120.8, 115.5, 114.5, 97.9 (a pair of peaks at the aromatic region is 
overlapped); HRMS (ESI, positive): m/z calcd. for C22H16N ([M+H]+) 294.1280, 
found 294.1277.  
(Z)-10-(4-Methoxybenzylidene)-10H-indolo[1,2-a]indole (2c): it was isolated by 
PTLC (hexane/dichloromethane = 9/1). The title compound was obtained as a yellow 
solid (24.5 mg, 76%); mp 120-122 °C; 1H NMR δ 8.61 (d, J = 8.7 Hz, 1H), 8.51 (d, 
J = 8.7 Hz, 1H), 7.83 (d, J = 6.9 Hz, 1H), 7.68-7.66 (m, 3H), 7.62-7.58 (m, 1H), 
7.45-7.31 (m, 3H), 7.08 -7.04 (m, 3H), 6.87 (s, 1H), 3.90 (s, 3H); 13C NMR δ 159.8, 
136.9, 136.1, 133.5, 132.7, 131.3, 130.3, 129.7, 128.9, 128.3, 124.8, 123.0, 122.5, 
121.9, 115.3, 114.4, 114.1, 97.8, 55.5 (two pairs of peaks at the aromatic region are 
overlapped);  HRMS (ESI, positive): m/z calcd. for C23H17NNaO ([M+Na]+) 
346.1203, found 346.1202.  
(Z)-10-(4-Fluorobenzylidene)-10H-indolo[1,2-a]indole (2d): it was isolated by 
PTLC (hexane/dichloromethane = 9/1). The title compound was obtained as yellow 
solid (17.0 mg, 55%); mp 106-108 °C; 1H NMR δ 8.61 (d, J = 8.7 Hz, 1H), 8.51 (d, 
J = 8.2 Hz, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.71-7.68 (m, 3H), 7.64-7.60 (m, 1H),  
7.46-7.32 (m, 3H), 7.23-7.17 (m, 2H), 7.07 (s, 1H),  6.81 (s, 1H); 13C NMR δ 164.1 
(d, J = 247.3 Hz), 136.6, 136.3, 134.9, 134.8, 133.5, 132.0, 130.7, 130.4 (d, J = 8.4 
Hz), 128.7, 125.6, 123.1, 123.0, 122.2 (d, J = 8.9 Hz), 121.4, 120.9, 115.8, 115.6 (d, 
J = 21.8 Hz), 114.4, 97.8; 19F NMR δ -113.4;   HRMS (ESI, positive): m/z calcd. for 
C22H14FN ([M]+) 311.1105, found 311.1105. 
(Z)-10-(4-(Trifluoromethyl)benzylidene)-10H-indolo[1,2-a]indole (2e): it was 
isolated by PTLC (hexane/dichloromethane = 9/1). The title compound was obtained 
as a yellow solid (18.1 mg, 50%); mp 125-127 °C; 1H NMR δ 8.63 (d, J = 8.7 Hz, 
1H), 8.52 (d, J = 8.7 Hz, 1H), 7.87-7.78 (m, 5H), 7.72 (d, J = 7.3 Hz, 1H),  7.67-7.63 
(m, 1H),  7.48-7.34 (m, 3H),  7.14 (s, 1H), 6.82 (s, 1H); 13C NMR δ 136.4, 133.5, 
131.7, 130.8, 129.3, 129.1, 129.0, 125.8 (q, J = 4.1 Hz), 125.1, 124.4, 123.6, 123.2, 
122.2, 121.4, 121.2, 121.0, 115.5, 114.5, 111.2, 103.2, 97.7; 19F NMR δ -62.4; 
HRMS (ESI, positive): m/z calcd. for C23H15F3N ([M+H]+) 362.1149, found 
362.1151.  
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(Z)-3-methoxy-10-(4-methoxybenzylidene)-10H-indolo[1,2-a]indole (2f): it was 
isolated by PTLC (hexane/dichloromethane = 7/3). The title compound was obtained 
as a yellow solid (23.7 mg, 67%); mp 162-164 °C; 1H NMR δ 8.53 (d, J = 8.7 Hz, 
1H), 8.39 (d, J = 9.2 Hz, 1H),  7.69-7.65 (m, 3H), 7.61-7.56 (m, 1H), 7.33-7.29 (m, 
1H), 7.25-7.20 (m, 1H),  7.08-7.03 (m, 4H), 6.79 (s, 1H), 3.91 (s, 6H); 13C NMR δ 
159.7, 155.3, 137.2, 135.9, 132.4, 131.3, 129.7, 128.9, 128.7, 128.3, 124.6, 122.8, 
122.3, 115.3, 114.9, 114.1, 112.2, 101.9, 97.4, 55.7, 55.5 (a pair of peaks at the 
aromatic region is overlapped); HRMS (ESI, positive): m/z calcd. for C24H20NO2 
([M+H]+) 354.1490, found 354.1489.  
(Z)-10-(4-Methoxybenzylidene)-2-methyl-10H-indolo[1,2-a]indole (2g): it was 
isolated by PTLC (hexane/dichloromethane = 7/3). The title compound was obtained 
as a yellow solid (20.6 mg, 61%); mp 182-184 °C; 1H NMR δ 8.59 (d, J = 8.2 Hz, 
1H), 8.30 (s, 1H), 7.71-7.65 (m, 4H),  7.61-7.75 (m, 1H),  7.33-7.30 (m, 1H),  7.21 
(d, J = 7.8 Hz, 1H), 7.06-7.03 (m, 3H),  6.81 (s, 1H),  3.90 (s, 3H),  2.66 (s, 3H); 13C 
NMR δ 159.7, 136.5, 136.2, 133.9, 132.8, 131.9, 131.4, 129.7, 128.8, 128.1, 124.9, 
123.8, 122.9, 121.9, 120.9, 115.4, 114.4, 114.1, 97.7, 55.5, 22.6 (a pair of peaks 96at 
the aromatic region is overlapped); HRMS (ESI, positive): m/z calcd. for C24H20NO 
([M+H]+) 338.1541, found 338.1539.  
(Z)-2-Fluoro-10-(4-methoxybenzylidene)-10H-indolo[1,2-a]indole (2h): it was 
isolated by PTLC (hexane/dichloromethane = 9/1). The title compound was obtained 
as a yellow solid (20.5 mg, 60%); mp 157-159 °C; 1H NMR δ 8.42 (d, J = 8.2 Hz, 
1H), 8.19 (d, J = 8.7 Hz, 1H),  7.74-7.71 (m, 1H), 7.68-7.57 (m, 4H),  7.35-7.32 (m, 
1H), 7.18-7.13 (m, 1H),  7.06-7.04 (m, 3H), 6.82 (s, 1H), 3.90 (s, 3H); 13C NMR δ 
161.0, 160.6 (d, J = 237.9 Hz), 159.8, 137.4 (d, J = 3.6 Hz), 135.8, 132.9 (d, J = 15.3 
Hz), 131.1, 129.7, 128.9, 128.3, 126.8, 124.9, 123.4, 122.2, 121.9 (d, J = 10.1 Hz), 
114.9, 114.2, 110.9 (d, J = 24.7 Hz), 101.3 (d, J = 28.3 Hz), 97.7, 55.5; 19F NMR δ 
-119.1;  HRMS (ESI, positive): m/z calcd. for C23H17FNO ([M+H]+) 342.1292, found 
342.1289.  
6-Pentylindolo[1,2-a]quinolone (3i): it was isolated by PTLC 
(hexane/dichloromethane = 9/1). The title compound was obtained as a green 
viscous oil (15.6 mg, 54%); 1H NMR δ 8.57 (d, J = 8.5 Hz, 1H), 8.48 (d, J = 8.0 Hz, 
1H), 7.87 (dd, J = 6.2, 1.7 Hz, 1H), 7.63 (dd, J = 6.2, 1.7 Hz, 1H), 7.57-7.54 (m, 1H), 
7.42-7.36 (m, 2H), 7.32-7.29 (m, 1H), 6.98 (s, 1H), 6.85 (s, 1H), 2.83 (t, J = 7.9 Hz, 
2H), 1.87-1.81 (m, 2H), 1.49-1.37 (m, 4H), 0.94 (t,  J = 7.3 Hz, 3H)  ; 13C NMR δ 
137.5, 136.0, 133.4, 132.3, 130.3, 128.3, 127.7, 124.7, 122.8, 121.9, 121.7, 121.3, 
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121.2, 115.2, 114.5, 95.3, 32.6, 32.0, 28.3, 22.7, 14.2; HRMS (ESI, positive): m/z 
calcd. for C21H22N ([M+H]+) 288.1747, found 288.1747.  
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The author synthesized planar chiral paracyclophanes with a hydroxyl or amino 
group through enantioselective ortho-lithiation and converted them to 
paracyclophanyl phosphites and phosphoramidites by reacting with 2,2’-biarylene 
phosphorochloridites. A ligand library was constructed by variation of substituents 
at the paracyclophane moiety or biarylene moiety derived from BINOL and biphenol 
as backbone. Most of these ligands were stable under air. The obtained phosphites 
were used as chiral ligands in the Pd-catalyzed allylic alkylation and Rh-catalyzed 
1,4-addition. Moderate enantioselectivity was achieved in both reactions and 
enantioinduction was governed by the planar chirality of paracyclophane. In case of 
phosphoramidites, their efficiency was examined in Pd-catalyzed allylic alkylation 
and Cu-catalyzed conjugate addition and moderate to good enantioselectivity was 
achieved. The cooperative effect of both planar and axial chiralities was examined 
in Cu-catalyzed conjugate addition.  
 
The author has developed a facile protocol for the synthesis of indoloindole 
derivatives by Au-catalyzed cycloisomerization of N-(2-alkynylphenyl)indoles. 
While 5-exo-dig products were selectively provided from aryl group-substituted 
alkyne, 6-endo-dig product was obtained from alkyl-substituted substrate. The 
author has also measured photophysical properties, such as UV-VIS absorption, and  
fluorescence spectroscopies, and fluorescence quantum yield. There was little effect 
of the substituents on the UV-VIS spectra. Fluorescence was observed at the visible 
region of 400-600 nm. Moderate quantum yield was achieved except phenyl-
substituted compound. 
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